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The vast majority of multicellular animals reproduce sexually, using the fusion of two 
gametes into a zygote to combine the genetic material of two parents into a single 
offspring. In most cases, the two distinct gametes, the sperm and the egg, are produced by 
two distinct sexes, the male and the female. These two sexes undergo distinct programs 
of sexual development, which are necessary to generate the two gamete types as well as 
the anatomical, physiological, and behavioral differences required for successful sexual 
reproduction.  
Sexual development can be broken down into two sequential steps. First, initial sex-
determining signals, either genetic or environmental, are interpreted by a sex-
determination pathway that sets the global sex of the animal. Then, sexual differentiation 
manifests this fate through sex-specific developmental events, such as cell divisions, cell 
migrations, and cell deaths that create the dimorphisms we observe between the sexes. 
This chapter will review what is known about sexual development in diverse animal 
lineages, examine this process in detail in the nematode worm Caenorhabditis elegans, 
highlight how the regulation of sexual differentiation represents a major gap in current 
knowledge of sexual development, and finally introduce a biochemical approach aimed at 
improving our understanding of this fundamental biological process. 
Animal sex-determination mechanisms are diverse 
While sexual development is widespread in animals, the molecular mechanisms used to 
regulate this fundamental process are surprisingly diverse. Initial sex-determining signals 
include a wide variety of genetic and environmental cues which are interpreted by sex-
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determination pathways that employ a wide variety of signaling and gene regulatory 
molecules. 
Initial sex-determination cues can be broken down into two types, environmental and 
genetic. For animals with genetic sex determination, the initial sex-determining cue is a 
heritable genetic factor. Perhaps the most familiar example of this type of system is the 
XY scheme utilized by humans and most other mammals. In this system, there are two 
distinct sex chromosomes, the X and Y, and an individual’s set of sex chromosomes 
determines whether it will develop as male or female. XY individuals develop as males 
due to the presence of a Y-encoded gene, SRY (Sex-determining region on Y) in humans 
(Berta et al., 1990; Sinclair et al., 1990), which initiates male-specific testis development 
in a genetically dominant fashion. In mammals, hormonal signaling from the testis directs 
male development throughout the animal, and individuals that lack male-specific 
hormonal signaling develop as females. Thus mammalian sex determination is cell non-
autonomous, with gonad sexual fate determining sex throughout the body. In some other 
species, such as the fruit fly Drosophila, the process is at least partially cell autonomous, 
with each cell determining sexual fate on its own (Spencer, 1927). In the XY system, 
offspring receive one sex chromosome from their father (either his X or Y) and one from 
their mother (one of her two Xes), so this system results in a roughly even sex ratio.  
In the ZW system, homogametic individuals (ZZ) develop as males, while heterogametic 
individuals (ZW) develop as females. This can be due to a dominantly female-promoting 
gene encoded on the W chromosome, such as in some amphibians (Yoshimoto et al., 
2008), or due to the dosage effects of Z-linked sex-determining genes, as in birds (Smith 
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et al., 2009). In this system, all offspring receive a Z from their father and either a Z or a 
W from their mother, which again results is a roughly even sex ratio.  
Genetic sex-determination systems are not always based on distinct sex chromosomes. 
For example, some insects have a single sex chromosome, which determines sex based 
on its copy number relative to the autosomes, such that animals with two X chromosomes 
develop as female, while animals with a single X develop as males. Bees utilize copy 
number of the entire genome to determine sex; unfertilized haploid eggs develop as 
males, while fertilized diploid eggs develop as females (Flanders, 1946). These systems 
can result in sex ratios that are far from even, and that can vary based on the method of 
reproduction, allowing these species to modify their sex ratios in response to 
environmental conditions or population dynamics. 
Chromosome-level genetic sex-determining mechanisms, such as the XY, ZW, and XO 
systems discussed above, include entire chromosomes that are present at different copy 
numbers in the two sexes. A two-fold expression difference in all the genes on an entire 
chromosome would be lethal in most cases, but such organisms have evolved dosage 
compensation mechanisms to equalize the expression of sex-linked genes between the 
sexes. In mammals, dosage compensation is achieved via complete inactivation of one of 
the two X chromosomes in female animals (Plath, Mlynarczyk-Evans, Nusinow, & 
Panning, 2002). In Drosophila, males double the rate of transcription from their single X 
chromosome (Meller & Kuroda, 2002), while C. elegans hermaphrodites halve the 
transcriptional output of both of their X chromosomes (Meyer, 2005).  
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Environmental cues can also serve as initial sex-determining signals. Many reptiles use 
incubation temperature as such a signal, with eggs incubated a certain temperatures 
developing as males, and eggs raised at other temperatures developing as females (Bull & 
Vogt, 1979). The amphipod Gammarus duebeni uses photoperiod to influence sex, with 
individuals reared during longer days developing mostly as males, and individuals reared 
during shorter days developing mostly as females (Bulnheim, 1966). Some fish rely on 
social cues, with the dominant individual in a group developing as female while 
subordinate animals develop as male, or vice versa (Robertson, 1972). In these examples, 
sex ratios obviously vary greatly based on environmental conditions, often in ways that 
confer a clear adaptive benefit. 
These varied initial sex-determining signals are interpreted by genetic sex-determination 
pathways that also show great diversity, utilizing a wide variety of signaling mechanisms 
and molecules to set the sex of the animal. The Drosophila sex-determination pathway 
relies heavily of regulators of alternative splicing (Salz, 2011), while transcription factors 
and hormonal signaling figure prominently in mammalian systems (Sekido & Lovell-
Badge, 2013). C. elegans utilizes a wide variety of intracellular and extracellular 
signaling molecules in sex determination, which will be described in detail later in this 
chapter. Sex-determination mechanisms evolve rapidly, and there seems to be little 
restriction on what types of genes can be recruited into a sex-determining role, resulting 
in a remarkable diversity of sexual regulators. 
Common themes in sexual development 
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Despite all this diversity, certain conserved features of sexual development have 
emerged. One common theme is that these diverse systems usually culminate in a single 
global sexual regulator that translates the upstream sex-determination pathway into a 
binary male-female decision. While these terminal sexual regulators are diverse, they 
typically encode a transcriptional factor that directs the coordinated execution of sex-
specific differentiation events via direct transcriptional regulation of target genes. 
One particular group of transcription factors, the DM-domain family, has emerged as a 
conserved component of sexual development in diverse animal lineages (Raymond et al., 
1998). DM-domain proteins play roles in the sexual development of all organisms in 
which they have been comprehensively examined, and may represent an ancestral family 
of sexual regulators. Members of this family have been shown to function at all levels of 
sexual development. The Y-linked DMY (DM domain gene on Y) of Medaka (Matsuda 
et al., 2002) and the W-encoded DMW of some amphibians (Yoshimoto et al., 2008) 
function as initial sex-determining cues. In Drosophila, the DM domain protein DSX 
(Doublesex) lies downstream of initial sex-determining cues and functions as the terminal 
regulator of sex, directing sex-specific differentiation throughout the animal (Hildreth, 
1965). C. elegans has several members of this gene family, and though none of them 
function in sex determination, at least three of them, mab-3, dmd-3, and mab-23, play 
important roles in the regulation of particular sex-specific differentiation events (Lints & 
Emmons, 2002; Mason, Rabinowitz, & Portman, 2008; Yi, Ross, & Zarkower, 2000).  
It has been hypothesized that while upstream components of sex-determination pathways 
may be easily gained and lost through evolution, downstream components such as 
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regulators of sexual differentiation are more constrained and therefore more likely to be 
conserved (Wilkins, 1995). The DM-domain proteins are the only known example of 
broadly conserved sexual regulators, but the degree to which other downstream sexual 
regulators may be conserved is largely unknown. This is due in part to the fact that few 
such regulators have been identified, even in species in which sex-determination 
mechanisms are fairly well understood, limiting the opportunity to systematically 
compare regulators of sexual differentiation in diverse lineages. 
Sex determination in C. elegans 
C. elegans has perhaps the best-understood sex-determination pathway of any animal, 
making it an excellent system in which to study sexual development. C. elegans 
determines sex genetically with an XO system (Nigon, 1951). XX animals develop as 
hermaphrodites, which are somatically female but capable of producing both eggs and 
sperm. C. elegans hermaphrodites produce and store a limited number of sperm in late 
larval development, allowing them to produce a few hundred progeny via self-
fertilization as adults without receiving sperm from a male. XO animals develop as 
males, which produce only sperm and must mate with a hermaphrodite in order to 
reproduce. All hermaphrodite sperm contain an X chromosome, with rare exceptions 
(~1/500) lacking an X due to errors in meiosis. Since males are XO, only half of their 
sperm contain an X, so half of the progeny resulting from a mating will also be male. 
This results in a system in which males are produced quite rarely in wild-type populations 
of purely hermaphrodite animals, but at close to 50% in populations where a significant 
number of males are already present.   
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The sex-chromosome complement is interpreted by a global sex-determination pathway, 
whose activity determines the sexual fate of all somatic cells in the animal (Figure 1.1). 
Core members of this pathway were identified in genetic screens for sex reversals and 
other major defects in sexual development (J. Hodgkin, 1980; J. A. Hodgkin & Brenner, 
1977), and subsequent epistasis analysis has placed these core genes in a linear pathway 
with alternating male-promoting and female-promoting activities, with each gene 
functioning to repress the gene immediately downstream of it (J Hodgkin, 1983; J. 
Hodgkin, 1984; Plenefisch, DeLong, & Meyer, 1989). This results in a back-and-forth 
regulatory cascade of alternating on and off genes which is in opposite phase in the two 
sexes (Figure 2.1).   
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Figure 1.1. Somatic sex determination in C. elegans. The sex-determination pathway in 
C. elegans in comprised of a negative regulatory cascade that transduces the X:Autosome 
ratio into the activity of the global master regulator TRA-1, a transcription factor that 
directs all aspects of sexual differentiation in the worm, primarily by repressing the 
transcription of genes that promote male development. Female promoting factors are 







The X:A ratio sets the activity of xol-1 
The most upstream gene in this pathway is xol-1 (XO lethal-1) (Miller, Plenefisch, 
Casson, & Meyer, 1988; Rhind, Miller, Kopczynski, & Meyer, 1995), which is a male-
promoting gene encoding an acidic protein structurally related to members of the GHMP 
family of small molecule metabolic kinases (Luz et al., 2003). XOL-1, however, does not 
bind ATP and its molecular function remains unknown. xol-1 activity is regulated by the 
X:A ratio in a complex manner, involving several X-signaling elements (XSEs) that 
repress xol-1 activity acting in opposition to several autosomal-signaling elements 
(ASEs) that promote xol-1 activity.  
Genetic experiments indicate that there are at least four distinct XSEs (Akerib & Meyer, 
1994). Three of these XSEs have been cloned and characterized and have been shown to 
repress xol-1 activity at two distinct levels. The nuclear hormone receptor SEX-1 (Signal 
element on X-1) (Carmi, Kopczynski, & Meyer, 1998) and the ONECUT homeodomain 
protein CEH-39 (C. elegans homeobox-39) (Gladden & Meyer, 2007) repress xol-1 at the 
transcriptional level, by directly binding to multiple sites in the xol-1 promoter. The RNA 
binding protein FOX-1 (Feminizing gene on X-1) directs alternative splicing of the xol-1 
transcript that results in the formation of an inactive splice variant (J. Hodgkin, Zellan, & 
Albertson, 1994; Nicoll, Akerib, & Meyer, 1997; Skipper, Milne, & Hodgkin, 1999). The 
two ASEs that have been characterized, the T-box transcription factor SEA-1 (Signal 
element on autosome-1) (Powell, Jow, & Meyer, 2005) and the zing-finger protein SEA-
2 (Huang, Zhang, & Zhang, 2011), both function to activate xol-1 transcription, again by 
directly binding to the xol-1 promoter. Thus the xol-1 promoter serves as a site of 
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competition between X-linked transcriptional repressors and autosome-linked 
transcriptional activators (Farboud, Nix, Jow, Gladden, & Meyer, 2013). 
This system is extremely sensitive to altered X:A ratios. In the wild type situation, it 
distinguishes between X:A ratios of 0.5 (1X:2A) and 1.0 (2X:2A), but experiments with 
polyploid animals have shown that it can reliably distinguish ratios of 0.67 (2X:3A), and 
0.75 (3X:4A) (Madl & Herman, 1979). This sort of ratiometric mechanism of sex 
determination is not universal in all species with XO sex-determination systems. For 
example, Drosophila appears to rely primarily on X chromosome counting (XSEs), 
without significant contributions from autosomal chromosomes (ASEs), to determine sex 
(Erickson & Quintero, 2007). The relative contributions of XSEs and ASEs in other 
species with XO sex-determination systems are currently unknown. 
xol-1 represses the DCC via repression of sdc-2 
Since males and hermaphrodites have different numbers of X chromosomes, a dosage 
compensation mechanism has evolved to equalize the expression of X-linked genes 
between the sexes. The upstream portion of the sex-determination pathway, from xol-1 to 
sdc-2, regulates both sex determination and dosage compensation, thus ensuring that both 
processes are functioning in the same mode.  
When active, as in wild-type XO animals, xol-1 functions to repress sdc-2 (sex 
determination and dosage compensation defect-2), leading to XX-specific expression of 
the SDC-2 protein (Dawes et al., 1999), although the molecular nature of this regulatory 
interaction is unknown. SDC-2 forms a dosage compensation complex (DCC) with a pair 
of zinc-finger proteins called SDC-1 and SDC-3. The DCC, which is a variant form of 
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the condensin complex and is normally active only in XX animals, functions to reduce 
the expression level of all X-linked genes by 2-fold, thus equalizing the expression of X-
linked genes in XX and XO animals (Meyer, 2005). It accomplishes this by directly 
binding to both X chromosomes and reducing their transcriptional output to half that of 
non-DCC bound X chromosomes.  
SDC-2 is the only sex-specifically expressed member of this complex, and ectopic 
expression of SDC-2 in XO animals is sufficient to initiate dosage compensation of the 
single X chromosome, causing lethality (Dawes et al., 1999). Thus xol-1 mediated 
repression of sdc-2 is responsible for the sex-specific activity of the entire complex. 
A DCC containing SDC-2 represses her-1 
The DCC also functions to repress a single autosomally-encoded gene, her-1 
(hermaphroditization of XO-1), which is required for normal sex determination (J. 
Hodgkin, 1980). DCC repression of her-1 occurs through direct binding to the her-1 
locus and transcriptional repression, but is mechanistically distinct from X chromosome 
repression. The DCC is targeted to the her-1 locus by SDC-3 rather than SDC-2, and the 
her-1-bound complex does not include the DPY-21 subunit found in the X chromosome-
bound complex (Yonker & Meyer, 2003). The complex induces 20-fold transcriptional 
repression of her-1 (Trent et al., 1991), much stronger than the 2-fold repression induced 
on the X chromosomes. 
her-1 represses tra-2 
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her-1 encodes a small secreted protein (Perry et al., 1993), and functions in a cell non-
autonomous manner to promote male development (Hunter & Wood, 1992). This cell 
non-autonomous step may help coordinate the sexual fate of cells throughout the animal, 
helping to avoid reproductively incompetent intersex states (Hunter & Wood, 1992). The 
only described function of her-1 is to repress tra-2 (transformer-2), which encodes the 
patched-related transmembrane protein TRA-2A (Kuwabara, Okkema, & Kimble, 1992). 
HER-1 binds directly to the transmembrane protein TRA-2A (Hamaoka, Dann, 
Geisbrecht, & Leahy, 2004; Kuwabara, 1996), preventing it from performing its female-
promoting function. 
tra-2 represses the fem genes 
TRA-2A represses the function of three fem (feminization of XX and XO) genes, fem-1, -
2, and -3. Similar expression of fem gene mRNAs in both sexes suggests that their 
repression by TRA-2A is post transcriptional (Ahringer, Rosenquist, Lawson, & Kimble, 
1992; Gaudet, VanderElst, & Spence, 1996; Pilgrim, McGregor, Jackle, Johnson, & 
Hansen, 1995), and TRA-2A has been shown to physically interact with FEM-3 (Mehra, 
Gaudet, Heck, Kuwabara, & Spence, 1999), suggesting that a protein-protein interaction 
between TRA-2A and FEM-3 is likely responsible for this repression. 
The fem genes repress tra-1 
The major function of the fem genes is the repression of tra-1, which occurs primarily at 
the post-translational level. FEM-1, an ankyrin repeat containing protein (Spence, 
Coulson, & Hodgkin, 1990), FEM-2, a serine/threonine phosphatase (Chin-Sang & 
Spence, 1996; Pilgrim et al., 1995), and the novel protein FEM-3 (Ahringer et al., 1992) 
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form a complex with the E3 ubiquitin ligase CUL-2 (Cullin-2) that targets the TRA-1 
protein for proteasomal degradation (Starostina et al., 2007). 
tra-1 regulates sex throughout the animal 
tra-1 is the most downstream gene in the sex-determination pathway, and functions as the 
terminal global sexual regulator in C. elegans (J. Hodgkin, 1987). Like most terminal 
sexual regulators, tra-1 encodes a transcription factor, specifically a C2H2 zinc-finger 
transcription factor related to the vertebrate GLI proteins (Zarkower & Hodgkin, 1992). 
The tra-1 locus produces two transcripts, encoding a larger protein called TRA-1A and a 
smaller protein known as TRA-1B. TRA-1B does not bind DNA and has no described 
biological activity (Zarkower & Hodgkin, 1993). TRA-1A is C-terminally cleaved to 
generate the functional transcriptional regulator (Schvarzstein & Spence, 2006), which 
will simply be called TRA-1 in this thesis. Genetic experiments have shown that tra-1 
activity is both necessary and sufficient to promote female somatic development, 
indicating that TRA-1 and its downstream targets are responsible for generating all sexual 
dimorphism in the worm (J. Hodgkin, 1987).  
A number of other players impact the core sex-determination pathway 
In addition to the core pathway members described above, a number of other genes have 
been shown to impact the sex-determination decision. Many of these genes were 
identified in the same genetic screens that identified the core components, or in follow-up 
screens looking for enhancers or suppressors of particular sex-determination alleles. One 
such gene encodes the calpain protease TRA-3 (Barnes & Hodgkin, 1996), which 
functions with tra-2 to repress the fems, likely by cleaving TRA-2A to generate an 
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intracellular fragment with feminizing activity (Sokol & Kuwabara, 2000). Another 
encodes the RNA-binding protein SUP-26 (Suppresor-26), which represses tra-2 at the 
translational level by binding to a specific site in the 3’ UTR of the tra-2 mRNA. These 
genes and other peripheral components of the sex-determination pathway may serve to 
stabilize the pathway, ensuring coordinated sexual development throughout the entire 
animal and the avoidance of deleterious intersex states.  
The core sex-determination pathway also functions in the germ line, although with the 
addition of a few features not present in the soma. The pathway functions through the fog 
(feminization of germ line) genes in the germ line, which function downstream of tra-1 to 
control germ cell sexual fate but play no role in somatic sex determination. In addition, 
the fem genes appear to act both upstream and downstream of tra-1 to control germ line 
sex (J. Hodgkin, 1986), while they appear to function solely through tra-1 in the soma. 
Finally, germ line sex switching in hermaphrodites requires translational repression of 
tra-2 to allow for hermaphrodite spermatogenesis (Doniach, 1986; Goodwin, Okkema, 
Evans, & Kimble, 1993; Jan, Motzny, Graves, & Goodwin, 1999), as well as translational 
repression of fem-3 for sustained oogenesis (Ahringer & Kimble, 1991; Ahringer et al., 
1992; Rosenquist & Kimble, 1988).  
Sexual differentiation downstream of tra-1 
As described above, C. elegans naturally occurs as two sexes, the XX hermaphrodite and 
the XO male. These two sexes exhibit a great deal of sexual dimorphism, much of which 
has been well characterized at the anatomic level. The complete cell lineage has been 
mapped for both the hermaphrodite and the male, meaning sexual dimorphisms can be 
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described in terms of specific cells and the presence or absence of specific cell division 
and cell death events (Kimble & Hirsh, 1979; Sulston, Albertson, & Thomson, 1980; 
Sulston & Horvitz, 1977; Sulston, Schierenberg, White, & Thomson, 1983). Many sexual 
dimorphisms are readily apparent (Figure 1.2), including differences in overall size, 
gonad shape, and tail morphology. Beyond these obvious dimorphisms are a multitude of 
more subtle sex differences; roughly a third of somatic cells in the adult exhibit some 
form of observable sexual dimorphism.  
Genetic screens have identified genes that regulate a subset of these sexual dimorphisms 
(J. Hodgkin, 1983a). Some of these regulators of sexual differentiation were later shown 
to be direct targets of TRA-1, directly connecting the global sex-determination pathway 
with particular sex-specific differentiation events. However, for many sexual 
dimorphisms no genetic regulators have been identified, and for others the connection 
between TRA-1 and their known regulators remains unclear. 
All known TRA-1 target genes regulate sexual differentiation in some way. The roles 
these genes play in sexual development were first identified based on observable loss-of-
function phenotypes, and their direct regulation by TRA-1 was determined later. Two of 
these genes, fog-1 and fog-3, function in the germ line to promote spermatogenesis (P. 
Chen & Ellis, 2000; Jin, Kimble, & Ellis, 2001). The other known TRA-1 targets direct 
specific somatic sexual differentiation events. egl-1 promotes the male-specific cell death 
of the hermaphrodite specific HSN neurons (Conradt & Horvitz, 1999), while ceh-30 
promotes the male-specific survival of the CEM neurons (Peden, Kimberly, Gengyo-
Ando, Mitani, & Xue, 2007). mab-3 functions to repress yolk-protein synthesis in the 
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male (Shen & Hodgkin, 1988; Yi et al., 2000), and also functions with dmd-3 to promote 
male-specific differentiation in the tail (Mason et al., 2008; Yi et al., 2000). All of these 
targets promote specific aspects of male development, suggesting that TRA-1 promotes 
female development primarily by repressing male-promoting genes. 
While simple genetic screens have been successful in identifying a subset of sexual 
regulators, the genetic control of a great deal of the sexual dimorphism in the worm 
remains uncharacterized, highlighting the need for new approaches aimed at identifying 
regulators of sexual differentiation.
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Figure 1.2. Sexual dimorphisms in C. elegans. C. elegans exists as two distinct sexes, 
which exhibit extensive sexual dimorphism. A few of the most obvious dimorphisms and 






Identifying regulators of sexual differentiation; a new approach 
Biochemical techniques can provide a complementary approach for the identification of 
genes that function in the regulation of sexual differentiation. They have the advantage of 
being able to identify certain types of genes that cannot be found with simple genetic 
screens, such as genes that lack strong loss-of-function phenotypes due to redundancy, or 
pleiotropic genes with very strong loss-of-function phenotypes in early development that 
mask a later role in sexual development.  
Chromatin immunoprecipitation followed by deep sequencing (ChIP-seq) is one such 
biochemical approach that can be used when an important transcriptional regulator, such 
as TRA-1, is known. This approach identifies regions of the genome where that protein 
binds and implicates nearby genes as putative targets worthy of closer examination. As 
described above, several known TRA-1 targets function as regulators of sexual 
differentiation, and the tra-1 null phenotype of nearly complete sex reversal suggests that 
essentially every sexual differentiation event involves a TRA-1 target at some level. Thus 
identifying the complete set of TRA-1 targets would presumably identify regulators of 
sexual differentiation events throughout the worm, providing a valuable list of candidate 
genes to examine for roles in sexual development, as well as a paradigm for 
understanding how sex-determination pathways regulate sexual differentiation on the 
scale of an entire organism. 
The following chapters will describe efforts to expand our understanding of sexual 
development through the identification of TRA-1 binding sites throughout the genome of 
the worm. Chapter 2 describes the use of ChIP-seq to identify a substantial fraction of 
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sites bound by TRA-1, as well as the use of reporter transgenes and RNAi to examine the 
function of the associated genes that serve as candidates to mediate its sex-determining 
roles in different tissues. Chapter 3 discusses the implications of these findings, and 
describes future investigations aimed at broadening our understanding of how TRA-1 and 
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How sexual regulators translate global sexual fate into appropriate local sexual 
differentiation events is perhaps the least understood aspect of sexual development. Here 
we have used Chromatin Immunoprecipitation followed by deep sequencing (ChIP-seq) 
to identify direct targets of the nematode global sexual regulator TRA-1, a transcription 
factor acting at the interface between organism-wide and cell-specific sexual regulation 
to control all sex-specific somatic differentiation events. We identified 184 TRA-1 
binding sites in C. elegans, many with temporal- and/or tissue-specific TRA-1 
association. We also identified 78 TRA-1 binding sites in the related nematode C. 
briggsae, 19 of which are conserved between the two species. Some DNA segments 
containing TRA-1 binding sites drive male-specific expression patterns, and RNAi 
depletion of some genes adjacent to TRA-1 binding sites results in defects in male sexual 
development. TRA-1 binds to sites adjacent to a number of heterochronic regulatory 
genes, some of which drive male-specific expression, suggesting that TRA-1 imposes sex 
specificity on developmental timing. We also found evidence for TRA-1 feedback 
regulation of the global sex-determination pathway: TRA-1 binds its own locus and those 
of multiple upstream masculinizing genes, and most of these associations are conserved 
in C. briggsae. Thus TRA-1 coordinates sexual development by reinforcing the sex-
determination decision and directing downstream sexual differentiation events.  
Introduction 
Sexual development requires an initial sex-determination decision followed by sex-
specific differentiation events that establish anatomical, physiological, and behavioral 
differences between the sexes. While the sex-determination switch has been well studied 
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in many animals, the molecular and genetic mechanisms by which sexual fate 
subsequently is manifested represent a major gap in our understanding of sexual 
development. Here we address this question in the nematode C. elegans. 
Sex is determined genetically in C. elegans: embryos with two X chromosomes (XX) 
develop as self-fertile hermaphrodites - females that transiently make sperm - whereas 
embryos with one X chromosome (XO) develop as males (Nigon, 1951). The sex 
chromosome complement sets the activity of TRA-1, a transcription factor that directs 
sexual differentiation throughout the animal (Zarkower & Hodgkin, 1992) (Fig. 2.1). 
High TRA-1 activity in XX animals promotes female differentiation, while low TRA-1 
activity in XO animals allows male differentiation (J. Hodgkin, 1987). Sexual 
dimorphism is extensive, with roughly a third of adult somatic cells showing obvious sex 
differences (Sulston & Horvitz, 1977), and depends on tra-1 activity. Null mutations in 
tra-1 cause XX animals to develop as fertile pseudomales, whereas tra-1 gain-of-function 
mutations cause XO animals to develop as fertile females (J. Hodgkin, 1987). Indeed, 
stable strains have been constructed in which the genotype at the tra-1 locus determines 
sex independent of the sex chromosomes (J. Hodgkin, 1983b). Genetic mosaic analysis 
showed that tra-1 determines sex autonomously in most cells (Hunter & Wood, 1990), 
although cell signaling does play a role in coordinating the sex-determination decision 
among cells (Hunter & Wood, 1992) and in local inductions of sexual cell fate (Kimble, 
1981). 
tra-1 performs several distinct functions in sexual development. First, it directs female 
somatic development via transcriptional repression of genes that promote male 
differentiation. Examples include mab-3 (Yi et al., 2000) and dmd-3 (Mason et al., 2008), 
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which jointly control specific aspects of male tail development, and ceh-30 (Peden et al., 
2007) and egl-1 (Conradt & Horvitz, 1999), which regulate sex-specific cell deaths in the 
nervous system. Second, tra-1 regulates germ line sex determination by repressing fog-1 
and fog-3 to promote oogenesis (P. Chen & Ellis, 2000; P. J. Chen, Cho, Jin, & Ellis, 
2001). Additionally, tra-1 is required for proper cell organization in the early male 
somatic gonad (J. Hodgkin, 1987), and modulates membrane synthesis in the female 
germ line to facilitate oogenesis (Arur et al., 2011), though the TRA-1 targets functioning 
in these processes remain unknown. Identifying the suite of TRA-1 target genes and 
determining how they collectively guide sexual differentiation in C. elegans will provide 
a paradigm for understanding how sexual regulators translate global sexual fate into 
specific differentiation events. 
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Figure 2.1. Model for genetic control of C. elegans somatic sex determination. Minor 







TRA-1 chromatin association exhibits temporal and tissue specificity  
To identify TRA-1 binding sites genome-wide, we performed ChIP-seq using an antibody 
that detects both major TRA-1 isoforms and binds DNA-bound TRA-1 (Fig. 2.8) (Arur et 
al., 2011). We performed ChIP-seq in L2 larvae, L3 larvae, and spe-11 young adults, 
which fail to produce embryos due to non-functional sperm (L'Hernault, Shakes, & Ward, 
1988). We chose these timepoints, during which many TRA-1 dependent sex-specific 
differentiation events occur, in an effort to identify as many TRA-1 binding sites as 
possible. We also analyzed glp-4 young adults deficient for germ cells (Beanan & 
Strome, 1992) to examine tissue-specificity of TRA-1 binding. We then analyzed tra-
1(e1834) null mutant (J. Hodgkin, 1987, 1993) young adult pseudomales to identify sites 
enriched independently of TRA-1, which were excluded from further analysis. We 
identified a total of 184 sites that were specifically bound by TRA-1 in both biological 
replicates of at least one developmental condition (Table 2.1, Methods). The 184 TRA-1 
binding sites identified are fewer than typical for site-specific transcription factors. 
However, they likely include about half of the TRA-1 binding sites in C. elegans, 
because binding sites were identified near five of eight previously described TRA-1 
targets, dmd-3, mab-3, xol-1, fog-1, and fog-3. Binding was not observed near the 
previously described TRA-1 targets egl-1, ceh-30, and lin-39. The five previously 
described targets that were bound are required for sex-specific development in a greater 
number of cells than the three targets not bound, suggesting that binding may be cell 
type-specific and whole-animal ChIP-seq may not identify targets bound only in a small 
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number of cells. Alternatively, some targets may be bound at developmental timepoints 
we did not examine. 
TRA-1 binds in vitro to a nonamer DNA motif very similar to that recognized by its 
mammalian homolog GLI (Zarkower & Hodgkin, 1993) (Fig. 2.2A). The most 
significantly enriched motif at TRA-1 binding sites was a nearly exact match to this in 
vitro defined motif (Fig. 2.2A), found at 169 of 184 (92%) TRA-1 binding sites, 
indicating that most, but not all, sites are bound through this motif. TRA-1 may bind 
other sites via more divergent motifs or indirect recruitment by other factors. While most 
TRA-1 binding sites had this motif, only about 4% of the best matches to this motif in the 
C. elegans genome were bound by TRA-1 (Fig. 2.2B). In general, TRA-1 ChIP 
enrichment was stronger for sites with closer matches to the consensus motif, but many 
perfect matches were not detectably bound by TRA-1, and many bound sites had 
imperfect matches (Fig. 2.2B). Thus like many transcription factors (Lieb, Liu, Botstein, 
& Brown, 2001), TRA-1 binds DNA at most of its sites via the consensus binding 
sequence, but additional factors help determine whether TRA-1 binds this motif.  
To examine how TRA-1 DNA occupancy changes during development, we assessed 
ChIP enrichment at each of the 184 TRA-1 binding sites at each of the developmental 
conditions tested, counting significant enrichment in either of two replicates as an 
indication of TRA-1 binding (Fig. 2.2C). By this criterion, 32/184 sites were bound by 
TRA-1 in L2, 105 in L3, and 164 in spe-11 young adults, indicating an increase in TRA-1 
occupied sites as development progresses. Thus the previous suggestion that TRA-1 
might bind its target sites at all times and in all tissues, only causing sex-specific 
expression in the cells in which nearby regulatory elements are active (Zarkower, 2001), 
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appears unlikely at least for many of the sites identified here. To ask whether TRA-1 
associates tissue-specifically with its binding sites, we compared TRA-1 binding in glp-4 
(severely reduced germ line) and spe-11 (normal germ line but no fertilized embryos) 
young adults. Of 164 sites with significant enrichment in spe-11 animals, 45 were not 
bound in glp-4 (Table 2.2, Methods), suggesting that TRA-1 binds to these sites primarily 
in the germ line. These germ line-specific TRA-1 targets provide candidates for future 




Table 2.1. 184 sites in the C. elegans genome show significant TRA-1 ChIP enrichment 
in both biological replicates of at least one developmental condition. Sites that showed 
significant TRA-1 ChIP enrichment in tra-1(e1834) animals were excluded from this list. 
Sites are ordered by chromosomal position (column A). Columns B-E indicate the 
number of replicates that showed significant enrichment for each developmental 
condition at each site; 2 indicates significant enrichment was detected in both replicates, 
1 indicates significant enrichment in 1 of 2 replicates, and 0 indicates significant 
enrichment in neither replicate. Column F indicates whether each site shares an 
orthologous TRA-1 binding site in C. briggsae. Column G indicates the coding gene with 
the transcriptional start site nearest to the TRA-1 binding site. Column H indicates all 
genes within 10 kilobases (kb) of the TRA-1 binding site. Column I indicates the type of 
expression pattern observed for reporters containing this site. Column J lists all genes 
associated with a given site that were examined by RNAi, and any sex-specific 
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chrI : 10016505 fog-3 2 1 2 1    
C03C11.1, F10G8.2, eak−6, fog−3, 
npp−17     
chrI : 10517086 nlp-4 2 2 2 0    
F59C6.12, F59C6.14, F59C6.16, 
F59C6.2, F59C6.3, F59C6.5, 
F59C6.8, che−13, exos−3, nlp−4     
chrI : 10565280 pas-5 2 2 1 0    
F25H2.12, F25H2.6, F25H2.7, 
pas−5, rla−0, rtel−1, tct−1, 
ubc−25     
chrI : 10761847 daf-16 0 0 2 2    daf−16     
chrI : 10769587 F55A3.5 0 0 2 2    daf−16     
chrI : 10798821 marc-6 0 0 1 2    
C35E7.8, C35E7.9, F55A3.2, 
F55A3.3, marc−6     
chrI : 11202385 ztf-6 0 1 2 2    ins−36, ztf−6 
male-specific 
expression in the 
developing tail 
ztf-6, male tail defects 
- fused rays and 
reduced fan 
chrI : 11512609 F32B4.2 0 1 2 0    
F32B4.1, F32B4.2, F32B4.4, 
F32B4.5, F32B4.6, F32B4.8     
chrI : 11916110 hda-3 0 1 2 1    
R09B3.2, R09B3.3, exo−3, fdps−1, 
hda−3, mag−1, ubc−12, wve−1     
chrI : 12039858 F58D5.5 0 1 2 2 yes 
F58D5.5, F58D5.6, F58D5.7, 
F58D5.8, F58D5.9, ksr−2 
sex non-specific 
expression F58D5.5 
chrI : 12520488 K11D2.4 1 2 2 2    
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chrI : 13325048 gcy-35 0 0 2 0    
T04D3.5, W08E3.2, gcy−35, 
pde−1     
chrI : 13331055 T04D3.5 0 1 2 0    
T04D3.5, W08E3.2, W08E3.4, 
gcy−35, snr−2, tag−210     
chrI : 13411282 C01A2.1 0 0 1 2    
C01A2.1, W05H12.1, W05H12.2, 
nlp−38     
chrI : 14030225 ZC334.12 0 1 2 2    
ZC334.12, ins−24, ins−25, ins−26, 
ins−27, ins−29, ins−30     
chrI : 14162185 C37A5.1 0 1 2 1    
C37A5.1, C37A5.11, C37A5.3, 
C37A5.7, fipr−22, fipr−23, fipr−24 
sex non-specific 
expression   
chrI : 1836861 egl-30 0 1 2 0    
C53H9.2, C53H9.3, Y71G12B.28, 
egl−30, emr−1, nlp−12, rpl−27, 
tag−96   egl-30 
chrI : 2299756 epg-2 0 1 2 2    
Y39G10AR.11, Y39G10AR.21, 
Y39G10AR.9, cdk−7, epg−2, icp−1, 
tpxl−1 
sex non-specific 
expression   
chrI : 2727709 Y71F9B.6 0 0 1 2    
Y71F9B.2, Y71F9B.6, Y71F9B.8, 
dnj−30, lin−17, snr−7, yop−1     
chrI : 2864169 Y71F9AL.11 0 0 2 2    
W10C8.5, W10C8.6, Y71F9AL.10, 
Y71F9AL.11, Y71F9AL.12     
chrI : 3210729 fog-1 2 2 2 2    
Y54E10A.13, Y54E10A.17, fog−1, 
rom−5     
chrI : 4032639 unc-73 0 0 2 1    unc−73, unc−89     
chrI : 4933144 F28B3.4 0 0 2 0    
F28B3.1, F28B3.4, F28B3.5, 
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chrI : 5033358 C46H11.3 0 0 0 2    
C46H11.3, C46H11.6, C46H11.7, 
lfe−2     
chrI : 5843045 col-54 0 1 1 2    
F33D11.1, F33D11.2, F33D11.5, 
F33D11.6, F33D11.7, ceh−12, 
col−54, obr−4     
chrI : 6007736 C06A5.12 0 1 2 0    
C06A5.1, C06A5.12, C06A5.2, 
C06A5.8, rnf−1, unc−94     
chrI : 7214885 nhr-23 0 0 2 0    
C01H6.2, C01H6.3, C01H6.4, 
C01H6.6, nhr−23, tag−298     
chrI : 7475444 T28F4.1 0 1 2 2 yes T28F4.1, T28F4.3, ZK524.4, asic−2     
chrI : 7500597 C26C6.8 0 0 2 0    
C26C6.6, C26C6.8, T28F4.4, 
T28F4.5, T28F4.6, glb−8, pbrm−1     
chrI : 7715772 lsy-22 0 0 1 2    F27D4.4, F27D4.7, lsy−22     
chrI : 824241 ZC123.1 0 0 2 0    ZC123.3     
chrI : 8409884 lin-28 0 1 1 2    
F02E9.1, F02E9.3, F02E9.7, 
T19A6.3, T19A6.4, lin−28, sin−3 
male-specific 
expression in 
body wall muscle   
chrI : 851609 Y95B8A.8 0 0 2 2    
Y95B8A.7, Y95B8A.8, ZC123.1, 
ZC123.4     
chrI : 8709006 cdk-8 0 0 2 0    cdk−8, cle−1, tlf−1     
chrI : 8792355 sup-17 0 1 2 2    F36A2.2, F36A2.3, mfb−1, sup−17 
sex non-specific 
expression   
chrI : 9854145 K10C3.2 0 1 1 2 yes 
K10C3.2, K10C3.4, K10C3.5, 
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chrII : 10502785 pqn-47 0 1 2 1    
F59B10.2, F59B10.3, ZK666.12, 
ZK666.14, ZK666.8, pqn−47     
chrII : 10528184 mab-10 0 1 2 1    
F59B10.4, F59B10.5, F59B10.6, 
R166.2, R166.3, mab−10 no expression mab-10 
chrII : 11103267 C09H10.5 0 2 1 2    
C09H10.10, C09H10.5, C09H10.7, 
C09H10.9, glb−4, mat−2, nasp−1, 
nuo−1, rpl−41, rpl−42     
chrII : 11688152 kel-1 0 0 1 2    
C47D12.2, C47D12.4, C47D12.5, 
C47D12.8, VF13D12L.1, kel−1, 
sfxn−1.4, tars−1     
chrII : 1236838 lin-42 0 0 2 0    F53A10.2, lin−42 
male-specific 
expression in the 
developing tail   
chrII : 12549783 F49C5.10 0 1 2 1    
F49C5.10, F49C5.11, F49C5.12, 
F49C5.4, F49C5.5, F49C5.9     
chrII : 13291657 ztf-22 0 0 2 0    Y48C3A.5, ztf−22 
sex non-specific  
expression   
chrII : 13738123 R06B9.5 0 1 2 2    
R06B9.5, Y54G9A.9, bub−3, 
mig−14 no expression mig-14 
chrII : 13836026 ins-37 2 0 0 0    
F08G2.4, F08G2.5, F08G2.7, 
his−42, his−43, his−44, ins−37     
chrII : 13852762 F08G2.8 2 1 0 0    F08G2.8, Y51H1A.1, Y51H1A.2     
chrII : 14244807 jmjd-2 0 0 2 2    Y54G11A.2, hmg−1.1, jmjd−2 
sex non-specific 
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chrII : 1470737 col-70 0 0 2 0    
H17B01.5, Y51H7C.1, Y51H7C.13, 
Y51H7C.15, col−70     
chrII : 15209387 spsb-1 0 0 1 2    spsb−1     
chrII : 162336 etr-1 0 2 0 0    
T01D1.7, T25D3.2, T25D3.3, 
T25D3.4, etr−1     
chrII : 1851935 C52E2.3 0 0 0 2    
C16C4.18, C52E2.2, C52E2.3, 
C52E2.4, C52E2.5, C52E2.8, 
fbxb−95, fbxb−96, fbxb−97     
chrII : 3376793 bath-9 0 1 1 2    
T06D4.1, T06D4.2, Y49F6C.2, 
Y49F6C.7, Y49F6C.8, bath−10, 
bath−23, bath−9 
sex non-specific 
expression   
chrII : 3439757 C16C8.17 0 1 1 2    
C16C8.14, C16C8.16, C16C8.17, 
C16C8.18, C16C8.2, C16C8.20, 
C16C8.21, C16C8.22, C16C8.4, 
C16C8.5     
chrII : 3786698 T24E12.13 0 1 0 2    
T24E12.1, T24E12.11, T24E12.13, 
T24E12.2, T24E12.3, Y8A9A.2, 
Y8A9A.3, Y8A9A.4, fbxb−99     
chrII : 4376731 ntl-2 0 0 2 2    
B0286.1, B0286.3, fkh−6, lat−2, 
ntl−2, try−9     
chrII : 5336805 F09E5.14 0 0 2 2    F09E5.14, F09E5.9, vhp−1     
chrII : 5599784 C17G10.10 2 2 1 0    
C17G10.1, C17G10.10, C17G10.2, 
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chrII : 5901848 tsp-18 0 0 2 2    
F55C12.1, lin-4, F59G1.4, 
F59G1.8, cgt−3, tsp−18, vps−35 
male-specific 
expression in the 
developing tail   
chrII : 6935045 F22D3.5 0 0 2 1    F22D3.2, F22D3.4, F22D3.5     
chrII : 8091653 ltd-1 2 2 1 0    K02C4.3, ltd−1, sfxn−5, sre−2     
chrII : 915308 fbxc-29 0 0 0 2    
clec−44, fbxa−200, fbxc−24, 
fbxc−27, fbxc−28, fbxc−29, 
fbxc−30, fbxc−31, fbxc−33     
chrII : 9301031 C01G6.9 0 0 0 2    C01G6.9, acs−7, cam−1     
chrII : 9726527 cutl-2 0 1 2 2    
Y53C12A.11, Y53C12A.6, cutl−2, 
mab−3, wee−1.3     
chrII : 9728870 cutl-2 2 2 2 2 yes 
Y53C12A.11, Y53C12A.6, 
Y53C12B.2, cutl−2, mab−3     
chrII : 9746211 Y53C12B.1 0 0 2 1    
Y53C12B.1, Y53C12B.2, 
Y53C12B.7, ZK1321.1, mab−3, 
nos−3     
chrIII : 10096662 bath-43 0 0 2 2    
T16H12.11, T16H12.2, T16H12.4, 
bath−43, kel−10, srt−55     
chrIII : 10632610 Y39A1A.9 0 2 2 2 yes 
Y39A1A.10, Y39A1A.12, 




chrIII : 10634106 Y39A1A.9 0 1 2 1 yes 
Y39A1A.10, Y39A1A.12, 
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chrIII : 10759189 K01G5.9 0 1 2 0    
K01G5.10, K01G5.3, K01G5.5, 
K01G5.9, dpy−28, hpl−2, rnf−113     
chrIII : 11185869 tra-1 0 2 2 2 yes tra−1     
chrIII : 11188157 tra-1 0 2 1 0    tra−1     
chrIII : 11243471 rsks-1 0 0 1 2    
Y47D3A.14, Y47D3A.32, aakb−2, 
elo−8, rsks−1     
chrIII : 11560690 ztf-29 0 1 2 1    
Y66D12A.10, Y66D12A.11, 
Y66D12A.13, Y66D12A.9, ztf−29     
chrIII : 1226441 pes-4 0 1 2 1    fbxa−21, pes−4     
chrIII : 12599056 Y111B2A.10 0 0 2 1    Y111B2A.10, Y111B2A.12, epc−1     
chrIII : 12613574 Y111B2A.12 0 0 1 2    Y111B2A.12, epc−1     
chrIII : 12919983 Y37D8A.16 0 1 2 1    
Y37D8A.16, Y37D8A.17, 
Y37D8A.18, Y37D8A.19, 
Y37D8A.21, flp−14     
chrIII : 13068332 Y39E4B.6 0 1 1 2    Y39E4B.6     
chrIII : 13734003 W06F12.3 0 2 1 1    W06F12.2, W06F12.3, lit−1, tyr−2   
W06F12.2, W06F12.3, 
lit-1 
chrIII : 147792 fbxb-84 0 0 0 2    
T17A3.10, T17A3.12, T17A3.2, 
T17A3.9, fbxb−81, fbxb−82, 
fbxb−83, fbxb−84, ver−1, ver−2     
chrIII : 154398 T17A3.9 0 0 0 2    
F40G9.8, T17A3.10, T17A3.12, 
T17A3.9, fbxb−83, fbxb−84, 
ver−1, ver−2     
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chrIII : 3953431 F37A8.5 0 0 2 2    F37A8.5, R10E9.2, R10E9.3     
chrIII : 4282668 tag-310 0 2 2 2    
R10E4.1, R10E4.3, R10E4.6, 
mcm−5, nth−1, tag−310 
sex non-specific 
expression R10E4.3, tag-310 
chrIII : 4667049 T23F11.4 0 0 1 2    T23F11.4, cdka−1, srg−13     
chrIII : 4748760 col-89 0 0 2 0    
B0393.3, B0393.8, F17C8.6, 
VB0393L.2, col−89, ras−2, rbg−3, 
rps−0, twk−6     
chrIII : 4796195 tag-325 0 1 2 1    
C38D4.4, C38D4.9, mel−28, 
pal−1, tag−325     
chrIII : 4950080 flh-2 0 1 1 2 yes 
C26E6.1, C26E6.3, C27F2.4, flh−2, 
fsn−1, rpb−2, vps−22 
sex non-specific 
expression C26E6.3, flh-2 
chrIII : 5423918 dnj-24 0 1 2 0    W03A5.4, dnj−24, grl−22     
chrIII : 5463824 F48E8.2 0 1 2 0    F48E8.2, F48E8.3, F48E8.4     
chrIII : 5622659 daf-4 0 0 1 2    C05D2.3, bas−1, daf−4     
chrIII : 5642861 ckk-1 0 1 2 1    ckk−1     
chrIII : 5653892 sdz-21 2 1 1 0    F54E7.6, ckk−1, sdz−21     
chrIII : 5953996 psf-1 0 0 2 0    
F25B5.2, F25B5.3, F25B5.5, 
F25B5.6, psf−1, ubq−1     
chrIII : 6421140 C05D11.7 0 1 2 0    
C05D11.10, C05D11.5, C05D11.7, 
C05D11.8, C05D11.9, nas−4 
sex non-specific 
expression   
chrIII : 6464203 dlc-1 0 1 1 2    
T26A5.2, T26A5.4, T26A5.5, 
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chrIII : 6603017 let-765 0 0 1 2    
F20H11.4, Y40D12A.2, let−765, 
mdh−2, srh−40     
chrIII : 7659500 ZK783.7 0 1 1 2    C18H2.1, ZK783.6, ZK783.7, flt−1     
chrIII : 8425205 cec-1 0 0 2 1    
ZK1236.1, ZK1236.5, ZK1236.9, 
cec−1, sor−1     
chrIII : 8658334 F22B7.9 0 0 1 2    
F22B7.1, F22B7.3, F22B7.9, 
dpy−19, flp−23   F22B7.9, dpy-19 
chrIII : 9765617 cbp-1 1 1 2 1    T05G5.9, cbp−1, rmd−1, vps−53     





chrIV : 1070629 Y55F3AM.14 0 1 1 2 yes Y55F3AM.14, csn−4 no expression   
chrIV : 12891986 K08D8.1 0 0 2 0    
K08D8.1, K08D8.10, K08D8.11, 
K08D8.12, K08D8.6, K08D8.7, 
K08D8.9, ZK896.4     
chrIV : 13395155 Y62E10A.13 0 1 2 1    
Y62E10A.13, Y62E10A.14, 
Y62E10A.19, Y62E10A.20, lsm−3, 
mdt−9     
chrIV : 1358226 col-105 0 0 2 0    col−104, col−105, rfc−2     
chrIV : 15719080 Y105C5A.17 0 0 2 0    Y105C5A.15, Y105C5A.17     
chrIV : 3016585 lin-22 0 1 2 1    
Y54G2A.27, Y54G2A.28, 
Y54G2A.29, Y54G2A.3, lin−22 
sex non-specific 
expression   
chrIV : 3079231 Y67D8C.1 0 0 2 0    
Y67D8C.1, Y67D8C.2, Y67D8C.9, 
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chrIV : 5063480 msp-57 2 1 0 0    
C02B10.6, C09B9.7, R13H9.5, 
R13H9.6, msp−53, msp−55, 
msp−57, rmd−6     
chrIV : 8782332 C33D9.13 0 1 1 2    
C33D9.10, C33D9.13, C33D9.3, 




chrIV : 9105139 fem-3 2 2 2 2 yes 
C01F6.2, C01F6.9, aly−1, cpna−3, 
fem−3, icl−1, lpl−1     
chrIV : 9130782 F23B2.3 2 1 0 0    F23B2.3, daf−10, tag−60     
chrIV : 9525966 elo-1 0 0 0 2    
C33A12.1, C33A12.19, F56H11.2, 
F56H11.6, elo−1, elo−7, nlp−35     
chrIV : 991285 egrh-2 2 2 2 0    
Y55F3AM.5, Y55F3AM.6, egrh−2, 
plx−1   Y55F3AM.6 
chrV : 10032506 acl-2 0 0 2 2 yes 
F57A8.1, K08H10.2, T06E8.2, 
acl−2, lea−1 
sex non-specific 
expression   
chrV : 10630912 mab-23 0 1 1 2    C32C4.1, mab−23 
male-specific 
expression in the 
adult tail   
chrV : 10717312 pph-1 0 1 2 2    T28B11.1     
chrV : 11175638 gpa-1 2 1 0 0    T19C4.5, cnc−10, gpa−1     
chrV : 11403414 nas-19 0 1 2 1    
K03B8.4, K03B8.6, K03B8.8, 




chrV : 11585317 srx-89 2 1 1 0    
nhr−68, srx−80, srx−82, srx−88, 

















 All genes within 10 kb 






chrV : 12465610 egl-10 0 0 2 1    F28C1.3, egl−10     
chrV : 13084117 C34B4.2 0 0 2 2    C34B4.2, C34B4.4, C34B4.7     
chrV : 14028579 T08G5.3 2 2 1 0    
T08G5.1, T08G5.15, T08G5.2, 
T08G5.3, ins−10, mtl−2, vps−39     
chrV : 14177804 ZC376.4 0 1 2 1    
ZC376.1, ZC376.2, ZC376.3, 
ZC376.4, ZC376.6, ZC376.8, 
ocam−1, trm−1     
chrV : 14358764 Y49A3A.4 2 1 0 0    
Y49A3A.1, Y49A3A.3, Y49A3A.4, 
cyn−1, vha−13     
chrV : 14463270 F08H9.3 2 2 1 0    
F08H9.2, F08H9.3, F08H9.4, 
bmk−1, clec−227, clec−57, coh−3, 
srz−97     
chrV : 14468666 srz-97 2 2 0 0    
F08H9.2, F08H9.3, F08H9.4, 
clec−227, clec−54, clec−56, 
clec−57, coh−3, srz−97     
chrV : 15029059 F14H8.8 2 1 0 0    
C25D7.1, C25D7.12, F14H8.2, 
F14H8.4, F14H8.5, F14H8.8, 
cng−1     
chrV : 15065357 C25D7.9 0 0 1 2    
C25D7.10, C25D7.15, C25D7.16, 
C25D7.5, C25D7.9, dnj−3, 
mcm−3, otub−1, rap−2, unc−76     
chrV : 16225834 F11A5.13 2 1 0 0    
F11A5.13, F11A5.15, F11A5.9, 
F21H7.12, F21H7.2, F21H7.3, 
clec−233, glc−1, gst−22, srh−98, 

















 All genes within 10 kb 






chrV : 17951199 Y59A8B.24 0 0 1 2    Y59A8B.24, dpy−21, gck−3     
chrV : 18346209 C08E8.3 0 1 0 2    
C08E8.10, C08E8.11, C08E8.2, 
C08E8.3     
chrV : 19212751 nhr-79 0 0 2 0    Y39B6A.1, nhr−79, oac−49, srr−2     
chrV : 19666471 Y43F8C.11 1 1 2 2    Y43F8C.11, mrp−7     
chrV : 20239880 Y113G7B.24 0 1 2 1    Y113G7B.15, Y113G7B.24, psa−1     
chrV : 20776772 F38A6.4 0 0 1 2    F38A6.4, F38A6.5, elp−1, hif−1     
chrV : 3703152 lin-40 0 1 2 0    T27C4.1, W08A12.1, lin−40     
chrV : 3714944 T27C4.1 0 1 2 0    T27C4.1, lin−40, str−30     
chrV : 5439212 F08F3.9 2 2 2 2 yes 
F08F3.1, F08F3.8, F08F3.9, acl−6, 
glc−3, rhr−1 no expression F08F3.9 
chrV : 6224451 W06H8.6 0 0 2 2 yes W06H8.6, rme−1, str−206     
chrV : 6355484 F13H6.1 0 0 2 0    F13H6.1, F13H6.3     
chrV : 9273768 ZK682.2 0 0 1 2    ZK682.2, ZK682.5, hlh−10     
chrX : 10079404 col-176 0 0 2 1    
W07E11.1, ZC373.4, ZC373.5, 
col−176, dao−4, flp−28     
chrX : 10188704 F21A10.4 0 1 2 2 yes 






chrX : 10435644 mig-15 0 0 2 1    C39B10.3, C39B10.4, mig−15     
chrX : 10480676 elt-2 0 2 0 1    
C33D3.3, C33D3.4, C39B10.7, 
elt−2, elt−4   elt-2 

















 All genes within 10 kb 






chrX : 11465227 lin-14 0 1 2 1 yes lin−14 no expression   
chrX : 11474368 lin-14 0 1 2 1    lin−14 
 
  
chrX : 12175862 F57G12.1 0 0 2 1    F57G12.1     
chrX : 12629406 tag-147 0 0 2 1    
R09A8.2, R09A8.5, col−182, 
tag−147     
chrX : 1319933 H42K12.2 0 2 2 2    
F21E9.2, H42K12.2, H42K12.3, 
pdk−1   H42K12.3, pdk-1 
chrX : 1327454 F21E9.2 0 1 2 0    F21E9.2, H42K12.2, pdk−1, ttr−37   H42K12.2 
chrX : 13687166 adm-2 0 1 2 1    adm−2, gck−4     
chrX : 14016867 C04C11.1 0 0 1 2    C04C11.1, tbc−19     
chrX : 15070232 H03G16.2 0 1 2 0    
H03G16.2, H40L08.2, H40L08.3, 
fbxa−96     
chrX : 15189293 T10B10.4 0 0 1 2    
T10B10.3, T10B10.4, phat−6, 
snt−7     
chrX : 15275776 kin-20 0 1 2 2 yes F46F2.5, jud−4, kin−20, ser−2 
male-specific 
expression in the 
developing tail   
chrX : 16128908 ZK1073.1 0 1 1 2    ZK1073.1, ZK1073.2     
chrX : 16286501 F52E10.3 0 0 2 0    
F52E10.2, F52E10.3, F52E10.4, 
sdc−1     
chrX : 16961323 F52G3.1 0 1 2 2 yes F52G3.1, F52G3.4 
sex non-specific 

















 All genes within 10 kb 






chrX : 17314852 ptr-5 1 2 2 2    C33E10.1, C53C11.4, ptr−5 
male-specific 
expression in 
body wall muscle ptr-5 
chrX : 17416863 crb-1 0 0 2 1    crb−1, osm−11     
chrX : 1840193 T26C11.3 0 0 2 1    
T26C11.2, T26C11.3, T26C11.4, 
ceh−21, ceh−41     
chrX : 1961789 F52D2.7 2 2 2 2    F52D2.7, fbxa−17, rgs−8.1, str−79 
sex non-specific 
expression F52D2.7 
chrX : 2329010 T01B6.1 2 1 1 0    T01B6.1, T01B6.4, aakg−4     
chrX : 2550805 F52H2.4 0 0 1 2    
F52H2.3, F52H2.4, F52H2.5, 
F52H2.6, aat−3     
chrX : 2899548 F52B10.3 0 0 1 2    
B0410.1, B0410.3, F52B10.3, 
nmy−1, vang−1 
sex non-specific 
expression   
chrX : 3945373 prl-1 1 1 1 2    T19D2.1, T19D2.3, prl−1     
chrX : 3970177 C16B8.3 0 0 2 0    
C16B8.2, C16B8.3, C16B8.4, 
lin−18     
chrX : 4307659 pqn-15 0 1 2 2    C52B9.8, pqn−15     
chrX : 4635878 C46C11.1 0 1 1 2    
C46C11.1, C46C11.2, C46C11.3, 
C46C11.4     
chrX : 5336701 C26B9.6 0 1 2 1    
C26B9.1, C26B9.2, C26B9.3, 
C26B9.5, C26B9.6, C26B9.7     
chrX : 6250602 W05H9.3 0 0 1 2    C14F11.1, W05H9.3     
chrX : 6279663 col-166 0 0 2 0    
T07H6.4, W05H9.1, W05H9.2, 

















 All genes within 10 kb 






chrX : 768330 ile-2 1 2 2 2    
T04G9.4, T04G9.7, aex−3, dyf−11, 
ile−2, nas−15, trap−2 
sex non-specific 
expression   
chrX : 8041025 xol-1 2 2 2 2    
C18A11.4, C18A11.6, C34D10.1, 
dim−1, xol−1     
chrX : 8059886 C18A11.3 0 0 2 0    
C18A11.1, C18A11.2, C18A11.3, 
dim−1   
 chrX : 806669 F25E2.1 0 2 1 0    F25E2.1, F25E2.2, F25E2.3, ifd−2    
chrX : 8286727 F13B9.1 0 1 2 1    
F13B9.1, F13B9.2, R09F10.3, 
fis−2, ksr−1     
chrX : 8568916 tag-279 0 0 1 2    F18E9.6, F18E9.8, tag−279, utx−1     
chrX : 9549120 F49E2.5 0 0 1 2    F49E2.5, nuc−1     
chrX : 9999508 grk-1 0 0 2 1    F19C6.2, F19C6.3, grk−1     
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Figure 2.2. Analysis of TRA-1 binding sites in the C. elegans genome. (A) Comparison 
of in vitro and in vivo derived TRA-1 binding motifs. (B) Analysis of TRA-1 occupancy 
at the 2713 closest matches to the TRA-1 motif found in the C. elegans genome. Motifs 
ordered by level of TRA-1 ChIP enrichment at the L3 stage. Left: Normalized TRA-1 
ChIP reads within a 4 kb window centered on each TRA-1 motif. Right: Strength of 
match to TRA-1 binding site for TRA-1 motifs, each bar represents an average score (-
log10 of p-value) for 20 motifs, sliding every 10 motifs. (C) Analysis of stage- and tissue- 
specific TRA-1 occupancy at 184 in vivo TRA-1 binding sites. Green boxes indicate a 
site was significantly bound (p-value < 10-5; fold enrichment >4) in at least one of two 





TRA-1 target genes are involved in male-specific sexual development 
We performed a pilot screen to evaluate whether our list of 184 TRA-1 binding sites can 
be used to find new sexual regulators. We used reporter analysis to identify TRA-1 bound 
DNA segments capable of driving sex-specific expression (Fig. 2.3A), and RNAi to 
identify genes adjacent to TRA-1 binding sites that are required for sexual differentiation 
(Fig. 2.3B). We chose 35 sites to examine with reporter analysis (Table 2.1), based on the 
strength of TRA-1 ChIP enrichment, enrichment in multiple stages, and the presence of 
strong TRA-1 motifs. Six TRA-1 bound segments drove obvious male-specific 
expression when fused to a minimal promoter and GFP (Fig. 2.3A, Fig. 2.4A). One was 
adjacent to the zinc-finger transcription factor ztf-6, and drove expression in male-
specific tail lineages. Another was adjacent to ptr-5, which encodes a protein distantly 
paralogous to Drosophila PATCHED. A ptr-5 reporter expressed male-specifically in 
body wall and stomatointestinal muscle as well as in sex muscles and some neurons of 
both sexes (Fig. 2.3A). Ablating the TRA-1 binding motif in this reporter activated 
expression in hermaphrodite body wall and stomatointestinal muscle cells (Fig. 2.3A). 
Another site was adjacent to mab-23, which encodes a DM-domain transcription factor 
that regulates male sexual differentiation (Lints & Emmons, 2002). A short region 
containing this site drove male-specific reporter expression in the tail (Fig. 2.3A). 
Ablation of the TRA-1 motif in this reporter caused ectopic expression in the 
hermaphrodite tail, but the expression was weak and variable, suggesting that TRA-1 
may act redundantly to repress mab-23, or that hermaphrodites lack an activator required 
for robust expression. mab-23 is one of three DM-domain transcription factors (along 
with mab-3 and dmd-3), implicated in male sexual differentiation and directly regulated 
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by TRA-1. Thus transcriptional regulation of this protein family, whose members also 
regulate sex in Drosophila and in vertebrates (Raymond et al., 1998), is a major 
mechanism by which TRA-1 regulates somatic sexual differentiation. 
Since previously described TRA-1 binding sites generally lie within or adjacent to the 
gene that is being regulated, we speculate that most of the 184 TRA-1 binding sites will 
regulate an overlapping gene or one of the two immediately adjacent non-overlapping 
genes. We identified 444 genes either containing or adjacent to a TRA-1 binding site, and 
chose 34 to examine by RNAi (Table 2.1), based on their proximity to strong TRA-1 
binding sites and predicted molecular functions consistent with a role in sexual 
differentiation. RNAi depletion of one of these genes, ztf-6, caused male tail defects (Fig. 
2.3B), including fused rays and a reduced fan. Thus ztf-6, ptr-5, and mab-23 are likely 
direct TRA-1 target genes with roles in male sexual differentiation. Since this pilot screen 
examined expression patterns for only 20% of the 184 TRA-1 binding sites, and RNAi 
phenotypes for only 8% of the 444 genes near these sites, it is highly likely that the ChIP 
data presented above can be used to find additional regulators of male differentiation. 
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Table 2.2. 45 TRA-1 binding sites show significant enrichment in at least one replicate of 
spe-11 animals but do not show significant enrichment in either glp-4 replicate, 
suggesting that TRA-1 binds to these sites primarily in the germ line. Sites are ordered by 
chromosomal position (column A). Columns B-E indicate the number of replicates that 
showed significant enrichment for each developmental condition at each site; 2 indicates 
significant enrichment was detected in both replicates, 1 indicates significant enrichment 
in 1 of 2 replicates, and 0 indicates significant enrichment in neither replicate. Column F 
indicates whether each site shares an orthologous TRA-1 binding site in C. briggsae. 
Column G indicates the coding gene with the transcriptional start site nearest to the TRA-
1 binding site. Column H indicates all genes within 10 kb of the TRA-1 binding site. 
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Peak center Nearest 
gene 






 All genes within 10 kb of site  
chrI : 10517086 nlp-4 2 2 2 0 no F59C6.12, F59C6.14, F59C6.16, F59C6.2, F59C6.3, F59C6.5, F59C6.8, 
che-13, exos-3, nlp-4 
chrI : 10565280 pas-5 2 2 1 0 no F25H2.12, F25H2.6, F25H2.7, pas-5, rla-0, rtel-1, tct-1, ubc-25 
chrI : 11512609 F32B4.2 0 1 2 0 no F32B4.1, F32B4.2, F32B4.4, F32B4.5, F32B4.6, F32B4.8 
chrI : 13325048 gcy-35 0 0 2 0 no T04D3.5, W08E3.2, gcy-35, pde-1 
chrI : 13331055 T04D3.5 0 1 2 0 no T04D3.5, W08E3.2, W08E3.4, gcy-35, snr-2, tag-210 
chrI : 1836861 egl-30 0 1 2 0 no C53H9.2, C53H9.3, Y71G12B.28, egl-30, emr-1, nlp-12, rpl-27, tag-96 
chrI : 4933144 F28B3.4 0 0 2 0 no F28B3.1, F28B3.4, F28B3.5, acl-11, imb-1 
chrI : 6007736 C06A5.12 0 1 2 0 no C06A5.1, C06A5.12, C06A5.2, C06A5.8, rnf-1, unc-94 
chrI : 7214885 nhr-23 0 0 2 0 no C01H6.2, C01H6.3, C01H6.4, C01H6.6, nhr-23, tag-298 
chrI : 7500597 C26C6.8 0 0 2 0 no C26C6.6, C26C6.8, T28F4.4, T28F4.5, T28F4.6, glb-8, pbrm-1 
chrI : 824241 ZC123.1 0 0 2 0 no ZC123.3 
chrI : 8709006 cdk-8 0 0 2 0 no cdk-8, cle-1, tlf-1 
chrII : 1236838 lin-42 0 0 2 0 no F53A10.2, lin-42 
chrII : 13291657 ztf-22 0 0 2 0 no Y48C3A.5, ztf-22 
chrII : 1470737 col-70 0 0 2 0 no H17B01.5, Y51H7C.1, Y51H7C.13, Y51H7C.15, col-70 
chrII : 5599784 C17G10.10 2 2 1 0 no C17G10.1, C17G10.10, C17G10.2, C17G10.6, C17G10.7, cdc-14 
chrII : 8091653 ltd-1 2 2 1 0 no K02C4.3, ltd-1, sfxn-5, sre-2 
chrIII : 10759189 K01G5.9 0 1 2 0 no K01G5.10, K01G5.3, K01G5.5, K01G5.9, dpy-28, hpl-2, rnf-113 
chrIII : 11188157 tra-1 0 2 1 0 no tra-1 
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Peak center Nearest 
gene 






 All genes within 10 kb of site  
chrIII : 4748760 col-89 0 0 2 0 no B0393.3, B0393.8, F17C8.6, VB0393L.2, col-89, ras-2, rbg-3, rps-0, 
twk-6 
chrIII : 5423918 dnj-24 0 1 2 0 no W03A5.4, dnj-24, grl-22 
chrIII : 5463824 F48E8.2 0 1 2 0 no F48E8.2, F48E8.3, F48E8.4 
chrIII : 5653892 sdz-21 2 1 1 0 no F54E7.6, ckk-1, sdz-21 
chrIII : 5953996 psf-1 0 0 2 0 no F25B5.2, F25B5.3, F25B5.5, F25B5.6, psf-1, ubq-1 
chrIII : 6421140 C05D11.7 0 1 2 0 no C05D11.10, C05D11.5, C05D11.7, C05D11.8, C05D11.9, nas-4 
chrIV : 12891986 K08D8.1 0 0 2 0 no K08D8.1, K08D8.10, K08D8.11, K08D8.12, K08D8.6, K08D8.7, 
K08D8.9, ZK896.4 
chrIV : 1358226 col-105 0 0 2 0 no col-104, col-105, rfc-2 
chrIV : 15719080 Y105C5A.17 0 0 2 0 no Y105C5A.15, Y105C5A.17 
chrIV : 3079231 Y67D8C.1 0 0 2 0 no Y67D8C.1, Y67D8C.2, Y67D8C.9, cpg-9 
chrIV : 991285 egrh-2 2 2 2 0 no Y55F3AM.5, Y55F3AM.6, egrh-2, plx-1 
chrV : 11585317 srx-89 2 1 1 0 no nhr-68, srx-80, srx-82, srx-88, srx-89, srx-90 
chrV : 14028579 T08G5.3 2 2 1 0 no T08G5.1, T08G5.15, T08G5.2, T08G5.3, ins-10, mtl-2, vps-39 
chrV : 14463270 F08H9.3 2 2 1 0 no F08H9.2, F08H9.3, F08H9.4, bmk-1, clec-227, clec-57, coh-3, srz-97 
chrV : 19212751 nhr-79 0 0 2 0 no Y39B6A.1, nhr-79, oac-49, srr-2 
chrV : 3703152 lin-40 0 1 2 0 no T27C4.1, W08A12.1, lin-40 
chrV : 3714944 T27C4.1 0 1 2 0 no T27C4.1, lin-40, str-30 
chrV : 6355484 F13H6.1 0 0 2 0 no F13H6.1, F13H6.3 
chrX : 1327454 F21E9.2 0 1 2 0 no F21E9.2, H42K12.2, pdk-1, ttr-37 
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Peak center Nearest 
gene 






 All genes within 10 kb of site  
chrX : 15070232 H03G16.2 0 1 2 0 no H03G16.2, H40L08.2, H40L08.3, fbxa-96 
chrX : 16286501 F52E10.3 0 0 2 0 no F52E10.2, F52E10.3, F52E10.4, sdc-1 
chrX : 2329010 T01B6.1 2 1 1 0 no T01B6.1, T01B6.4, aakg-4 
chrX : 3970177 C16B8.3 0 0 2 0 no C16B8.2, C16B8.3, C16B8.4, lin-18 
chrX : 6279663 col-166 0 0 2 0 no T07H6.4, W05H9.1, W05H9.2, col-166, lev-9 
chrX : 8059886 C18A11.3 0 0 2 0 no C18A11.1, C18A11.2, C18A11.3, dim-1 
chrX : 806669 F25E2.1 0 2 1 0 no F25E2.1, F25E2.2, F25E2.3, ifd-2 
 56 
 
 Figure 2.3. Newly identified TRA-1 target genes exhibit male-specific expression 
patterns and reduction-of-function phenotypes. (A) Genomic intervals containing 
TRA-1 binding sites drive male-specific reporter gene expression. ztf-6::gfp is expressed 
male-specifically in the developing tail (left). ptr-5::gfp is expressed male-specifically in 
body wall (arrows) and stomatointestinal muscle and the sex-specificity of this 
expression is dependent on the presence of a TRA-1 motif (center). mab-23::gfp is 
expressed male-specifically in the tail, and the sex-specificity of this expression is 
dependent on the presence of a TRA-1 motif (right). (B) RNAi of ztf-6 results in defects 






TRA-1 binds to and regulates the expression of genes that control developmental 
timing  
Developmental timing in C. elegans is controlled by a complex network of heterochronic 
regulatory genes (Moss, 2007). Heterochronic mutations cause defects in multiple aspects 
of male sexual development, probably by disrupting the timing of critical cell divisions 
(Nelson et al., 2011). Strikingly, among the roughly two-dozen heterochronic genes, 
TRA-1 bound adjacent to six, daf-12, kin-20, lin-4, lin-14, lin-28, and lin-42 (Fig. 2.4A, 
Table 2.1). DNA segments containing three of these sites, those adjacent to lin-42, kin-
20, and lin-4, drove strong expression in lineages that undergo male-specific 
developmental programs, particularly the P10.p and B lineages of the developing tail 
(Fig. 2.4B). A lin-28 reporter showed male-specific expression in body wall muscle, a 
sexually specialized cell type found in both sexes (Fig. 2.4C), and ablating the TRA-1 
binding motif activated expression in hermaphrodite body wall muscle (Fig. 2.4C). These 
results collectively indicate that TRA-1 directly represses transcription of heterochronic 
genes in hermaphrodites. 
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Figure 2.4. TRA-1 binding sites near four heterochronic regulatory genes drive 
male-specific expression. (A) TRA-1 associates with chromatin near lin-42, kin-20, lin-
4, and lin-28. TRA-1-ChIP (red) and input DNA tracks (black) are shown at same scale. 
Close matches to the TRA-1 consensus binding motif are indicated by vertical black bars 
above the ChIP trace. (B) Regions surrounding TRA-1 binding sites near lin-42, kin-20, 
and lin-4 drive reporter gene expression in male-specific cell lineages in the tail, 
including the P10.p lineage (bar) and B lineage (bracket). (C) The region surrounding the 
TRA-1 binding site near lin-28 drives male-specific expression in body wall muscle 
(arrows), and the sex-specificity of this expression is dependent on the presence of a 








TRA-1 feeds back onto the sex-determination pathway at multiple levels  
We also identified TRA-1 binding sites representing two forms of feedback regulation on 
the sex-determination pathway. First, the tra-1 locus contained three TRA-1 binding sites 
(Fig. 2.5A). Genetic evidence supports tra-1 autoregulation: the feminizing effect of 
dominant tra-1 gain-of-function alleles can be reduced by adding wild-type copies of the 
gene (J. Hodgkin, 1993), and many recessive hypomorphic tra-1 alleles show equivalent 
masculinization when either homozygous or hemizygous (Schedl, Graham, Barton, & 
Kimble, 1989). Second, we observed apparent feedback on upstream sex-determination 
genes. TRA-1 can bind to a site in the xol-1 promoter in vitro, and regulates xol-1 
reporter transgenes via this site (Hargitai et al., 2009). ChIP-seq confirmed in vivo TRA-1 
binding to this site (Fig. 2.5A), and also identified TRA-1 binding sites adjacent to fem-3 
and sup-26 (Mapes, Chen, Yu, & Xue, 2010), suggesting more extensive upstream 
feedback (Fig. 2.5A, Fig. 2.7, Table 2.1). A site near her-1 also showed TRA-1 binding, 
but below the significance cutoff applied. All of these upstream targets normally promote 
male development, suggesting that TRA-1 transcriptional repression provides multi-level 
reinforcement of the feminizing mode of the sex-determination switch.  
To further explore feedback regulation we focused on fem-3. Regulation of fem-3 in the 
XX germ line involves post-transcriptional repression (Ahringer & Kimble, 1991), but 
expression of FEM-3 in somatic tissues has not been described. A FEM-3::GFP fosmid 
reporter was expressed in the vas deferens region of the male somatic gonad, but 
undetectable in the hermaphrodite gonad (Fig. 2.6A). Ablating the TRA-1 motif activated 
expression in the somatic gonad of the hermaphrodite, with robust expression restricted 
to the spermatheca (Fig. 2.6A), though this ectopic FEM-3 expression did not result in 
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any obvious developmental defects. We also examined endogenous FEM-3 expression by 
immunofluorescence, which confirmed stronger expression in male than hermaphrodite 
soma (Fig. 2.6B). We conclude that somatic expression of fem-3 involves transcriptional 
feedback regulation by TRA-1, which potentially functions to reinforce the global sex-
determination decision.    
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Figure 2.5. TRA-1 feeds back on the sex-determination pathway at multiple levels. 
(A) C. elegans TRA-1 binds near the tra-1, xol-1, sup-26, and fem-3 loci. (B) C. briggsae 
TRA-1 binds near the Cbr-tra-1, Cbr-xol-1, and Cbr-fem-3 loci. A site near Cbr-sup-26 
showed occupancy by CBR-TRA-1, but below the threshold we applied. (C) Alignments 
of TRA-1 motifs (underlined) identified near the xol-1 and fem-3 loci in C. elegans, C. 







Figure 2.6. TRA-1 regulates fem-3 expression. (A) A FEM-3::GFP reporter is 
expressed in the vas deferens (arrow) of the male somatic gonad, but shows no 
expression in the hermaphrodite somatic gonad. FEM-3::GFP ΔTRA-1 is expressed in 
the spermatheca (arrowheads) of the hermaphrodite somatic gonad. (B) FEM-3 antibody 








TRA-1 targets are evolutionarily conserved  
TRA-1 homologs determine sex in other nematode species including Pristionchus 
pacificus (Pires-daSilva & Sommer, 2004) and C. briggsae, which are diverged from C. 
elegans by about 200 million years (MY) and 100 MY respectively. Despite the 
evolutionary stability of the TRA-1 sex-determining function, it is unknown whether any 
genes regulated by TRA-1 in C. elegans are also regulated in other species, although 
sequence analysis has shown that TRA-1 binding motifs are present near the C. briggsae 
orthologues of some identified C. elegans TRA-1 targets, including mab-3 and fog-3 (P. 
J. Chen et al., 2001; Yi et al., 2000). The TRA-1 antibody recognizes C. briggsae TRA-1 
(Arur et al., 2011), so we performed ChIP-seq in C. briggsae L3 larvae, and identified 78 
CBR-TRA-1 binding sites (Table 2.3). CBR-TRA-1 binding sites were highly enriched 
for the TRA-1 motif, which appears to be identical in the two species and was found at 54 
of 78 (69%) CBR-TRA-1 binding sites. For 64 of 78 CBR-TRA-1 binding sites, syntenic 
alignments unambiguously identified a single region in the C. elegans genome 
corresponding to the bound region in C. briggsae. 19 of these 64 syntenic regions 
coincided with one of the 184 C. elegans TRA-1 binding sites (Table 2.4), suggesting 
substantial conservation of TRA-1 regulation through nematode evolution. Notably, sites 
representing feedback regulation of the sex-determination pathway, including those 
adjacent to tra-1, fem-3, and xol-1, showed TRA-1 occupancy in both species (Fig. 2.5B). 
A site near Cbr-sup-26 also showed weak CBR-TRA-1 binding, but this was below the 
significance cutoff. Likewise, TRA-1 binding adjacent to the heterochronic genes daf-12, 




Table 2.3. 78 sites in the C. briggsae genome show significant CBR-TRA-1 ChIP 
enrichment in both replicates at the L3 stage. Sites are ordered by chromosomal position 
(column A). Column B indicates whether each site shares an orthologous TRA-1 binding 
site in C. elegans. Column C indicates the coding gene with the transcriptional start site 
nearest to the TRA-1 binding site. Column D indicates all genes within 10 kb of the 





Peak center Nearest gene Conserved in 
C. elegans? 
All genes within 10 kb of site 
chrI : 13237778 F58D5.5 yes F58D5.5, F58D5.9, Y47H9C.7, Y47H9C.8, hrp-2 
chrI : 13798238 RITIcx1693    F22G12.4, RITIcx1693, RITIcx223, RITIcx2590, RITIcx2783, RITIcx829 
chrI : 14827774 pbs-5    F31C3.6, K05C4.11, K05C4.2, RITIcx2013, RITIcx2132, Y54E5A.8, pbs-5 
chrI : 15270102 C49G9.1    C49G9.1, C49G9.2, T07D10.2, dlk-1 
chrI : 235622 T28F4.1 yes RITIcx2888, T28F4.1, asic-2 
chrI : 2730581 RITIcx2084    RITIcx2084, ppfr-1 
chrI : 3080227 D1007.18    D1007.10, D1007.18, D1007.19, D1007.3, RITIcx440, RITIcx680, rpl-24.1 
chrI : 5301075 K10C3.2 yes K10C3.2, RITIcx648, zig-1 
chrI : 6295162 D2005.6    D2005.6, R11A5.4, RITIcx2296 
chrI : 717335 RITIcx1578    RITIcx1578, RITIcx1908 
chrI : 82882 spr-4    F18C12.3, spr-4 
chrII : 11560488 daf-5    RITIIcx720, daf-5 
chrII : 13448967 RITIIcx2921    RITIIcx1492, RITIIcx2811, RITIIcx2921, RITIIcx3074 
chrII : 15058944 str-52    RITIIcx2135 
chrII : 3344987 ctns-1    F10B5.8, RITIIcx1624, ctns-1, ire-1, ulp-4 
chrII : 3481527 mig-5    F21H12.7, RITIIcx1891, RITIIcx1935, RITIIcx2029, T05C12.8, T05C12.9, cct-1, 
dylt-3, mig-5 
chrII : 4229168 rpl-5    F54C9.14, F54C9.3, F54C9.7, F54C9.9, RITIIcx741, bcs-1, col-38, rpl-5, stc-1 
chrII : 4287420 pqn-73    RITIIcx1818, RITIIcx1928, RITIIcx228, pqn-73 
chrII : 4340387 RITIIcx2671    R05H10.1, R05H10.7, RITIIcx2671, cdh-7 
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Peak center Nearest gene Conserved in 
C. elegans? 
All genes within 10 kb of site 
chrII : 4343058 R05H10.1    R05H10.1, R05H10.7, RITIIcx2671, cdh-7 
chrII : 4357247 K02B7.3    F26H11.6, K02B7.3, R05H10.7, RITIIcx2968 
chrII : 5236742 RITIIcx298    C18H9.5, RITIIcx1276, RITIIcx1653, RITIIcx298 
chrII : 64392 cutl-2 yes RITIIcx1849, Y53C12A.7, Y53C12B.7, cutl-2, mab-3 
chrII : 8928962 ztf-27    T09F3.2, ztf-27 
chrII : 9393776 C32D5.8    C32D5.10, C32D5.11, C32D5.7, C32D5.8, RITIIcx216, lgg-1 
chrII : 949962 tag-165    C01G6.5, acs-7, tag-165 
chrIII : 10206018 RITIIIcx523    F54F2.7, RITIIIcx523, RITIIIcx691, prx-19, ztf-1 
chrIII : 11568504 glod-4    C16C10.9, RITIIIcx2687, glod-4, wht-3 
chrIII : 12409078 ncl-1    RITIIIcx1084, RITIIIcx2739, ncl-1 
chrIII : 12414616 RITIIIcx2739    RITIIIcx1581, RITIIIcx2739, RITIIIcx599, ncl-1 
chrIII : 1500846 flp-14    Y37D8A.16, cco-2, flp-14 
chrIII : 5174689 Y39A1A.9 yes RITIIIcx1744, Y39A1A.12, Y39A1A.13, Y39A1A.9, dhs-11 
chrIII : 5177473 RITIIIcx1744 yes RITIIIcx1744, Y39A1A.12, Y39A1A.9, dhs-11 
chrIII : 5690802 C26E6.3 yes C26E6.3, C27F2.4, F09F7.3, RITIIIcx1344, RITIIIcx2289, flh-2 
chrIII : 5842765 tra-1 yes RITIIIcx1562, RITIIIcx2080, tra-1 
chrIII : 5845101 tra-1    RITIIIcx1562, tra-1 
chrIII : 5861049 RITIIIcx1917     
chrIII : 6456958 RITIIIcx1077    F38H4.6, RITIIIcx1077, RITIIIcx1725, RITIIIcx1791, RITIIIcx2347, unc-116 




Peak center Nearest gene Conserved in 
C. elegans? 
All genes within 10 kb of site 
chrIV : 17096198 Y55F3AM.14 yes K08C9.1, K08C9.2, RITIVcx1204, Y55F3AM.11, Y55F3AM.14 
chrIV : 17102957 RITIVcx1425 yes RITIVcx1204, RITIVcx1425, RITIVcx2235, RITIVcx2283, Y55F3AM.14 
chrIV : 2584368 lst-4    RITIVcx3222, RITIVcx631, lst-4 
chrIV : 4393894 fem-3 yes RITIVcx421, aly-1, fem-3 
chrIV : 503519 RITIVcx125    F26D10.11, RITIVcx125, RITIVcx1727, RITIVcx3209, atgp-1, clec-196 
chrIV : 505965 RITIVcx125    F26D10.11, RITIVcx125, RITIVcx1641, RITIVcx1719, RITIVcx1727, RITIVcx2414, 
RITIVcx3209, atgp-1, clec-196 
chrIV : 8666177 F40F11.3    F12F6.1, F40F11.2, F40F11.3, F40F11.4, RITIVcx128, RITIVcx664 
chrIV : 8669739 F40F11.4    F12F6.1, F40F11.2, F40F11.3, F40F11.4, RITIVcx163 
chrV : 10770915 nhr-232    C12D8.1, C12D8.9, akt-1, col-148, nhr-232, ric-4, rop-1 
chrV : 1157238 RITVcx3257    F41E6.15, F41E6.5, F41E6.7, F41E6.9, RITVcx3257, RITVcx554, smk-1, tag-196 
chrV : 11596809 F44E7.5    C28F5.4, F44E7.2, F44E7.5, F44E7.7, F44E7.9, nhr-142 
chrV : 11962141 K08B12.3 yes K08B12.3, W06H8.6, rme-1 
chrV : 11965916 W06H8.6    K08B12.3, W06H8.6 
chrV : 13362140 RITVcx788    K07B1.6, K07B1.7, RITVcx788, coq-6, try-5, ucp-4 
chrV : 15147176 RITVcx1517    H39E23.2, RITVcx1517, par-1 
chrV : 15420942 acl-2    acl-2, lea-1 
chrV : 15436743 F57A8.1 yes F57A8.1 
chrV : 5174150 C39F7.5    C39F7.1, C39F7.5, rab-1 
chrV : 6090376 sri-4    gei-7, sri-4, srp-1 
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Peak center Nearest gene Conserved in 
C. elegans? 
All genes within 10 kb of site 
chrV : 9388694 pyc-1    D2023.3, D2023.5, RITVcx1985, RITVcx2306, RITVcx603, RITVcx754, pyc-1 
chrX : 10553020 H28G03.1    H28G03.1, H28G03.2, RITXcx193, pqn-62 
chrX : 11149158 hbl-1    hbl-1 
chrX : 12194961 mdl-1    R03E9.2, abts-4, mdl-1 
chrX : 13770267 C34D10.1    C34D10.1, F45E1.1, RITXcx103 
chrX : 13797945 RITXcx1939    RITXcx1872, RITXcx1939, RITXcx2332, xol-1 
chrX : 1681119 F57G12.1    F57G12.1 
chrX : 17184558 RITXcx1058    RITXcx1058, RITXcx1913, RITXcx2426, RITXcx272 
chrX : 17710315 rab-14    K09E9.3, ent-2, erv-46, nipi-3, rab-14 
chrX : 17711844 rab-14    K09E9.3, ent-2, erv-46, nipi-3, rab-14 
chrX : 18067286 kin-20 yes F46F2.5, RITXcx1358, jud-4, kin-20 
chrX : 18811378 RITXcx2809    RITXcx1771, RITXcx2809, RITXcx3079, T24C2.5 
chrX : 2819398 F52G3.1 yes F52G3.1, RITXcx3687, RITXcx422 
chrX : 4438001 RITXcx2925    RITXcx1138, RITXcx2925, lgc-40 
chrX : 4843547 RITXcx1227    RITXcx1227, RITXcx2006, ftt-2 
chrX : 5080456 lin-14 yes lin-14 
chrX : 5082986 lin-14    F48C5.2, lin-14 
chrX : 6394175 daf-12 yes M79.2, daf-12 
chrX : 7108033 RITXcx754 yes F21A10.1, F21A10.4, RITXcx1303, RITXcx3488, RITXcx754, nucb-1 
chrX : 8165713 RITXcx1033    K10B3.5, K10B3.6, RITXcx1033, RITXcx173, RITXcx726 
 73 
 
Table 2.4. 19 orthologous sites show binding by TRA-1 in the C. elegans genome and 
binding by CBR-TRA-1 in the C. briggsae genome. Sites are ordered by chromosomal 
position (column A). Columns B-E indicate the number of replicates that showed 
significant enrichment for each developmental condition at each site; 2 indicates 
significant enrichment was detected in both replicates, 1 indicates significant enrichment 
in 1 of 2 replicates, and 0 indicates significant enrichment in neither replicate. Column F 
indicates the coding gene with the transcriptional start site nearest to the TRA-1 binding 
site (in C. elegans). Column H indicates all genes within 10 kb of the TRA-1 binding site 




Peak center Nearest 
gene 






 All genes within 10 kb of site  
chrI : 12039858 F58D5.5 0 1 2 2 yes F58D5.5, F58D5.6, F58D5.7, F58D5.8, F58D5.9, 
ksr-2 
chrI : 7475444 T28F4.1 0 1 2 2 yes T28F4.1, T28F4.3, ZK524.4, asic-2 
chrI : 9854145 K10C3.2 0 1 1 2 yes K10C3.2, K10C3.4, K10C3.5, nhr-62, zig-1 
chrII : 9728870 cutl-2 2 2 2 2 yes Y53C12A.11, Y53C12A.6, Y53C12B.2, cutl-2, 
mab-3 
chrIII : 10632610 Y39A1A.9 0 2 2 2 yes Y39A1A.10, Y39A1A.12, Y39A1A.27, Y39A1A.8, 
Y39A1A.9, dhs-11, hpr-9 
chrIII : 10634106 Y39A1A.9 0 1 2 1 yes Y39A1A.10, Y39A1A.12, Y39A1A.27, Y39A1A.8, 
Y39A1A.9, dhs-11, hpr-9 
chrIII : 11185869 tra-1 0 2 2 2 yes tra-1 
chrIII : 4950080 flh-2 0 1 1 2 yes C26E6.1, C26E6.3, C27F2.4, flh-2, fsn-1, rpb-2, 
vps-22 
chrIV : 1064617 Y55F3AM.14 0 0 2 2 yes Y55F3AM.1, Y55F3AM.13, Y55F3AM.14, dcap-1 
chrIV : 1070629 Y55F3AM.14 0 1 1 2 yes Y55F3AM.14, csn-4 
chrIV : 9105139 fem-3 2 2 2 2 yes C01F6.2, C01F6.9, aly-1, cpna-3, fem-3, icl-1, 
lpl-1 
chrV : 10032506 acl-2 0 0 2 2 yes F57A8.1, K08H10.2, T06E8.2, acl-2, lea-1 
chrV : 5439212 F08F3.9 2 2 2 2 yes F08F3.1, F08F3.8, F08F3.9, acl-6, glc-3, rhr-1 
chrV : 6224451 W06H8.6 0 0 2 2 yes W06H8.6, rme-1, str-206 
chrX : 10188704 F21A10.4 0 1 2 2 yes F21A10.1, F21A10.2, F21A10.4, nucb-1 
chrX : 10637590 daf-12 0 1 2 1 yes M79.2, daf-12 
chrX : 11465227 lin-14 0 1 2 1 yes lin-14 
 75 
 
Peak center Nearest 
gene 






 All genes within 10 kb of site  
chrX : 15275776 kin-20 0 1 2 2 yes F46F2.5, jud-4, kin-20, ser-2 




Here we have used ChIP-seq to identify 184 binding sites of the nematode global sexual 
regulator TRA-1. A pilot analysis of genes adjacent to these sites identified seven new 
TRA-1 target genes that appear to promote male sexual differentiation based on male-
specific expression patterns and/or male-specific RNAi phenotypes. However, none of 
the targets we examined showed a hermaphrodite-specific reduction-of-function 
phenotype or expression pattern. Likewise, ChIP-seq indicated that TRA-1 feedback onto 
the upstream sex-determination pathway occurs exclusively on male-promoting genes 
(Fig. 2.7), consistent with their repression by TRA-1 in hermaphrodites. Additionally, 
12/256 (4%) of the genes adjacent to sites bound by TRA-1 at L2 or L3 showed male-
biased expression in published L4 RNA-seq analysis (Gerstein et al., 2010). In contrast, 
none of these genes showed hermaphrodite-biased expression. We cannot exclude that 
TRA-1 can activate as well as repress transcription like some other GLI proteins. 
However, our data support the view that TRA-1 functions primarily as a transcriptional 
repressor, generating sexually dimorphic gene expression by restricting the expression of 
its targets in the hermaphrodite. 
Our data and previous genetic analyses (Okkema & Kimble, 1991; Schedl et al., 1989) 
indicate that TRA-1 has two distinct roles in regulating sexual development: it controls 
sex-specific cell and tissue differentiation by regulating a suite of downstream effector 
genes, and it feeds back at multiple upstream steps to affect the primary sex-
determination decision (Fig. 2.7). TRA-1 binding near fem-3 and xol-1 has been 
conserved between C. elegans and C. briggsae, and sequences containing TRA-1 binding 
motifs also are conserved near these genes in C. brenneri and C. remanei (Fig. 2.5C). 
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Reporter analysis and immunofluorescence confirmed the role of TRA-1 as a repressor of 
fem-3 transcription in the hermaphrodite soma. Multicopy transgenes do not normally 
express in the germ line, so we have not yet examined whether this transcriptional 
feedback also occurs in germ cells; however the mutually exclusive germ line distribution 
of nuclear TRA-1 and FEM-3 (Arur et al., 2011) suggests that it may. Somatic FEM-3 
expression has not been shown previously (Rosenquist & Kimble, 1988) but is supported 
by genetic data: somatic feminization of tra-1(gf) males is suppressed by gain-of-function 
mutations in the fem-3 3’ UTR that do not affect fem-3 transcript levels (Schedl et al., 
1989). Thus FEM-3 activity is regulated through at least three separate means: the 
transmembrane receptor protein TRA-2 represses FEM-3 protein activity via physical 
interaction (Mehra et al., 1999), fem-3 mRNA is negatively regulated via the 3’ UTR (B. 
Zhang et al., 1997), and we find that fem-3 is also transcriptionally repressed by TRA-1. 
fem-3 therefore appears to be an important node for control of the sex-determination 
pathway. Feedback from TRA-1 may serve at least two purposes. First, we speculate that 
it renders the global sex-determination decision more robust and helps ensure the 
coordinated execution of downstream sexual differentiation events. Second, feedback 
loops might provide additional inputs to control the temporary switch from female to 
male sex determination that occurs in hermaphroditic species during germ line 
development.  
The TRA-1 binding sites we have identified provide a resource for identifying and 
functionally defining the suite of genes that control sexual differentiation in nematodes. 
The restricted male-specific expression patterns and limited male-specific developmental 
defects for putative target genes are consistent with the view that TRA-1 controls sexual 
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development by regulating many minor players in male development rather than a few 
major ones. To fully evaluate the roles these candidate target genes may play in sexual 
development it will be important to examine possible functional overlaps, such as those 
that occur between mab-3 and dmd-3 (Mason et al., 2008), as well as to perform 
phenotypic analysis in sensitized backgrounds and at finer scale. 
Sex-determination pathways impose sex specificity on the spatial and temporal control of 
development in animals with diverse body plans, behaviors, and physiologies. The 
conservation of TRA-1 binding between C. elegans and C. briggsae suggests substantial 
evolutionary conservation of sexual development within nematodes. However, TRA-1 is 
among the fastest evolving genes in Caenorhabditids (de Bono & Hodgkin, 1996), and its 
orthologues do not appear to regulate sex determination outside nematodes. DMRT genes 
(orthologues of the TRA-1 targets mab-3, mab-23, and dmd-3) determine sex in many 
other animals including insects and vertebrates (Matson & Zarkower, 2012). Comparing 
how TRA-1 and DMRT genes overlay sex specificity on development therefore may shed 
considerable light on the evolution of sexual development in metazoans.  
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Figure 2.7. Model for TRA-1 regulation of nematode sexual development. TRA-1 
represses sex-determination genes that globally promote male development, including 
xol-1, sup-26, fem-3, and possibly her-1, as well as sexual differentiation genes that 





Materials and Methods 
Worm strains and culture 
The following strains and alleles were obtained from the Caenorhabditis Genetics 
Center: wild type C. elegans (N2), wild type C. briggsae (AF16), LG I: spe-11(hc77), 
glp-4(bn2), LG II: rrf-3(pk1426), LG III: tra-1(e1834), LG IV: him-8(e1489), hT2[bli-
4(e937) let-?(q782) qIs48] (I;III). Animals were maintained in nematode growth medium 
(NGM) plates with added bacteria (Escherichia coli strain OP50) at 22°C, unless 
otherwise indicated.  
ChIP-seq 
To generate material for ChIP, gravid hermaphrodites were bleached and their eggs were 
collected and allowed to hatch overnight in M9. Synchronized animals were then grown 
in standard liquid culture conditions (wormbook.org) using HB101 bacteria as a food 
source, and staged by gonad migration and time. N2, AF16, and tra-1(e1834)/hT2[bli-
4(e937) let-?(q782) qIs48] animals were grown at 20°C; spe-11(hc77) and glp-4(bn2) 
animals were grown at 25°C. tra-1(e1834) homozygotes were sorted from tra-
1(e1834)/hT2[bli-4(e937) let-?(q782) qIs48] siblings using a COPAS BIOSORT 
SELECT (Union Biometrica, 350-5000-000) to collect GFP-negative animals. Two 
consecutive rounds of sorting were used to ensure a pure population of tra-1(e1834) 
homozygotes. Collected animals were separated from residual bacteria by sucrose 
flotation and washes in M9, and then frozen in liquid nitrogen.  
Frozen animals were physically disrupted by grinding in liquid nitrogen in a mortar and 
pestle, fixed in 1%PFA in PBS for 15 min at RT and post-fixed with 50mM glycine for 5 
min at RT. All subsequent steps were performed at 4°C. Material was pelleted, washed 
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3x in PBS with protease inhibitors, and resuspended in 1%SDS lysis buffer. Fixed 
chromatin was sheared with a Diagenode Bioruptor Standard, on the high setting for 7.5 
min total on time (15 min of 30 sec on, 30 sec off cycles). ChIP was performed as in 
(Murphy et al., 2010), using 2ug anti-TRA-1 antibody UMN163 per sample. Two 
biological replicates were performed for each developmental condition, using ~2 g frozen 
worms per replicate, with the exception of a single replicate of tra-1(e1834), which was 
performed on ~80,000 sorted animals. 
DNA recovered from ChIP was ligated to sequencing adapters containing an 8-base 
multiplexing barcode sequence. DNA libraries were sequenced to 36 or 50 nucleotides by 
Illumina Genome Analyzer II or Hi-seq instruments. All C. elegans reads were 
subsequently trimmed to the first 27 bases and aligned to the ce10 reference genome 
using Bowtie (Langmead, Trapnell, Pop, & Salzberg, 2009), accepting only uniquely 
mapped reads with up to two mismatches. For C. briggsae, 48-base reads were aligned 
using the same Bowtie program settings to the latest cb4 reference genome for peak 
analyses and to the cb3 reference genome for signal visualization. To visualize ChIP-seq 
signals in the UCSC genome browser and in the heat map, aligned reads were extended to 
200 bases, and the number of reads overlapping with each base of the genome was 
counted using Bedtools (Quinlan & Hall, 2010). The per-base read counts were then 
normalized to the genome-wide average in order to take the sequencing depth into 
account. Raw sequencing reads and processed data for genome browser visualization are 
available at Gene Expression Omnibus (GEO) website under accession ID GSE48917. 
TRA-1 binding site identification 
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ChIP enriched regions were identified by the MACS2 program (Y. Zhang et al., 2008) 
using input DNA sequencing reads as a reference. For C. elegans data sets, regions 
fulfilling a MACS2 p-value threshold of less than 10-5 and a fold enrichment threshold of 
greater than 4 were extracted. This threshold identified 86 regions in L2-stage replicate 1 
(DZ038); 111 regions in L2-stage replicate 2 (DZ039); 86 regions in L3-stage replicate 1 
(DZ012); 337 regions in L3-stage replicate 2 (DZ015); 2480 regions in spe-11 replicate 1 
(DZ023); 176 regions in spe-11 replicate 2 (DZ050); 129 regions in glp-4 replicate 1 
(DZ042); and 137 regions in glp-4 replicate 2 (DZ043) (Supplemental Table 2). Regions 
that were identified in both biological replicates of a single condition (≥1 base pair (bp) 
overlap) were subsequently extracted and merged. This process narrowed the candidate 
regions to 72 regions for the L2 stage; 81 regions for the L3 stage; 163 regions for spe-11 
young adults; and 107 regions for glp-4 young adults. Because some regions were 
identified in more than a single biological stage, we collected all regions in a single list 
and merged overlapping regions (≥ 1 bp). This yielded 257 candidate TRA-1-binding 
regions. Finally, we removed 73 candidate regions that overlap with regions with non-
specific TRA-1 ChIP-seq signals (see below). We reported the remaining 184 regions 
(Supplemental Table 1) as high confidence TRA-1 binding sites in C. elegans. 
To determine regions with non-specific TRA-1 ChIP-seq signal, we used TRA-1 ChIP-
seq data generated in the tra-1(e1834) null mutant. We first made 500 bp windows across 
the C. elegans genome with a 250 bp offset and determined the tra-1 mutant ChIP-seq 
read count for each window. These per-window counts followed a normal distribution 
with a mean count of 23.4 and standard deviation of 15.6. We identified 6439 windows 




For C. briggsae data sets, ChIP-enriched regions fulfilling a MACS2 p-value threshold of 
less than 10-5 and a fold enrichment threshold of greater than 3 were extracted. This 
threshold identified 377 regions in replicate 1 (DZ040) and 82 regions in replicate 2 
(DZ041). Seventy-eight regions were found in both replicates and identified as CBR-
TRA-1-binding sites at the L3 stage.  
Motif analysis 
100 bp regions centered around TRA-1 binding sites were searched for DNA motifs 
using the MEME-chip program (Machanick & Bailey, 2011) with a background Markov 
model constructed with genome-wide di-nucleotide frequencies. 2713 TRA-1 motif sites 
in the C. elegans genome were identified by FIMO program (Grant, Bailey, & Noble, 
2011) using a query DNA motif constructed by the 9-mer TRA-1 interacting sequences 
defined in vitro (Zarkower & Hodgkin, 1993), and a p-value threshold of 10-5.  
Expression analysis 
500-1000 bp regions surrounding TRA-1 binding sites were cloned into pPD107.94 (Fire, 
Harrison, & Dixon, 1990). ∆TRA-1 reporters were generated by replacing the invariant 
GG in the gggtGGtc consensus binging motif with AA, using the Agilent QuikChange 
XL site-directed mutagenesis kit. FEM-3::GFP was generated by recombineering fosmid 
WRM067dB02 according to (Tursun, Cochella, Carrera, & Hobert, 2009), with gfp 
coding sequence replacing the fem-3 stop codon. FEM-3::GFP ∆TRA-1 was also 
generated by recombineering according to (Tursun et al., 2009), making the same change 
as described above. Reporter constructs were injected with str-1::gfp as a co-injection 
marker (5-20 ng/uL reporter, 20 ng/uL str-1::gfp, sheared N2 genomic DNA to 100 
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ng/uL total DNA) into him-8(e1489) animals. Stable transgenic lines were assayed for 
gfp expression. 
RNAi 
him-8(e1489); rrf-3(pk1426) animals were used for all RNAi experiments, which were 
performed according to the standard C. elegans feeding RNAi protocol (wormbook.org). 
L4 hermaphrodite animals were placed on standard RNAi plates and their progeny were 
scored by DIC microscopy for defects in sexual development.  
FEM-3 Antibody Staining 
Antibody staining was as described in (Seydoux & Dunn, 1997). Wild type animals were 
analyzed as young adults. FEM-3 antibody was used at a 1:200 dilution. 
 86 
 
Figure 2.8. Characterization of anti-TRA-1 antibody UMN163 used in this study. 
(A) Western blot: UMN163 recognizes bands corresponding in size to the two major 
species of TRA-1 in N2 animals but not in tra-1(e1834) mutant animals. Asterisks denote 
the approximate sizes of major TRA-1 isoforms. (B) Immunofluorescence: UMN163 
shows nuclear staining in N2 animals but not in tra-1(e1834) mutant animals. (C) Gel-





Chapter 3  




Chapter 2 described a biochemical approach designed to identify genes involved in 
sexual development in C. elegans. ChIP-seq identified a substantial fraction of the TRA-1 
binding sites in the worm, generating a list of several hundred candidate sexual regulators 
that lie adjacent to the binding sites of this global sexual regulator. A preliminary 
examination of the function of these putative TRA-1 targets indicated that at least a few 
of them are expressed male-specifically and/or exhibit male-specific reduction-of-
function phenotypes, consistent with transcriptional repression by TRA-1. This chapter 
will highlight a few important remaining questions regarding the role of TRA-1 and its 
targets in sexual development and describe future investigations aimed at addressing 
these questions. 
Important questions concerning TRA-1 regulation of sexual development 
What is the complete set of TRA-1 target genes? 
The lists of 184 TRA-1 binding sites and 444 associated genes described in Chapter 2 
likely only include about half of the total TRA-1 targets in C. elegans. Five of the eight 
previously identified TRA-1 targets are on this list, but the known targets egl-1, ceh-30, 
and lin-39 are not. Not only did the sites near these genes fail to show the significant 
enrichment required to make the list of 184 TRA-1 binding sites, they showed essentially 
no enrichment at all in any of the TRA-1 ChIPs performed, despite compelling genetic 
and biochemical evidence that they are genuine TRA-1 binding sites (Conradt & Horvitz, 
1999; Peden et al., 2007; Szabo et al., 2009).  
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The most plausible explanation for their absence in these experiments is that whole 
animal ChIP-seq using this particular TRA-1 antibody fails to identify all TRA-1 binding 
sites in the worm. It is conspicuous that the three TRA-1 targets not identified are each 
responsible for the sexually dimorphic development of only a few cells, particularly in 
light of the fact that experiments with germ line-less glp-4 mutants suggest that TRA-1 
exhibits at least some tissue-specific binding. This suggests that TRA-1 binding at some 
sites may be restricted to only a few cells, and it may not be possible to identify these 
sites with whole animal ChIP-seq using an antibody to TRA-1. Two possible approaches 
to circumvent this problem and identify additional TRA-1 targets will be discussed at the 
end of this chapter. 
How do TRA-1 target genes control sexual development? 
Although the list of 444 putative TRA-1 target genes appears to be incomplete, it likely 
represents a significant portion of the complete set of C. elegans TRA-1 targets. A 
handful of these putative TRA-1 target genes have loss-of-function phenotypes that 
include obvious defects in sexual development, including the previously known targets 
mab-3 (J. Hodgkin, 1983a) and dmd-3 (Mason et al., 2008). However only one of the 34 
newly identified putative TRA-1 targets that were assayed, ztf-6, showed an obvious 
sexual differentiation defect when knocked down by RNAi.  
This is likely due in part to the difficulty in assigning each TRA-1 binding site to a 
particular target gene. TRA-1 binding sites have been shown to regulate target genes at 
distances of at least a few kb (Conradt & Horvitz, 1999), and in the compact genome of 
C. elegans, there are often several genes within a few kb of a particular TRA-1 binding 
site. All of these nearby genes could be considered putative targets, but it is likely that 
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only a single gene is regulated per binding site, meaning the list of 444 genes associated 
with 184 TRA-1 binding sites likely includes a maximum of about 184 genuine TRA-1 
targets. 
Even taking this difficulty into account, it is still striking how few of the putative TRA-1 
targets examined in Chapter 2 actually show defects in sexual development when 
knocked down by RNAi. Some of these genes may have subtle roles in sexual 
differentiation that are difficult to detect. Others may have roles that are masked by 
genetic redundancy, which has been observed in many developmental processes, 
including nematode sexual differentiation. The male-specific sexual regulators mab-3 and 
dmd-3 act in a partially redundant fashion to promote male tail tip morphogenesis (Mason 
et al., 2008). mab-3 mutant males have minor tail tip retraction defects at low penetrance, 
and dmd-3 mutant males have somewhat stronger retraction defects at higher penetrance, 
but mab-3; dmd-3 double mutant males show a completely penetrant full tail tip 
retraction defect. It is possible that other TRA-1 targets have similarly redundant roles in 
promoting other aspects of male differentiation, which cannot be revealed in single-gene 
knockdown experiments.  
Of course it is also possible that some of these TRA-1 binding sites do not function in 
sexual development, and are simply examples of transcription factor binding events that 
confer no significant benefit or detriment to the animal. Our cross-species ChIP data 
suggests that this is unlikely to be the case for at least a quarter of these sites, as roughly 
that proportion have been conserved through tens of millions of years of evolution, 
strongly suggesting that they are of biological significance. Determining the functional 
role of many of the putative TRA-1 targets on this list may be difficult, requiring 
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examinations at finer scale, in sensitized genetic backgrounds, or in compound mutants. 
However the presence of so many known sexual regulators on this list, including mab-3, 
dmd-3, mab-23, ztf-6, fog-1, fog-3, tra-1, fem-3, sup-26, and xol-1, suggests that it may be 
worth the effort, particularly for sites that are bound in both C. elegans and C. briggsae. 
Do terminal sexual regulators in other systems control sexual differentiation via similar 
targets? 
In addition to identifying the complete set of TRA-1 targets and determining what role 
they play in nematode sexual development, it will be interesting to see whether terminal 
sexual regulators in distantly related species control the homologues of these genes, and 
whether those homologues play similar roles in the sexual development of those species. 
Recent work in Drosophila has identified a partial set of targets for the terminal sexual 
regulator DSX (Luo, Shi, & Baker, 2011). None of the genes on this list of 23 DSX 
targets have a C. elegans homologue adjacent to a TRA-1 binding site, although this 
comparison is obviously limited by the small list of DSX targets. DSX ChIP-seq is 
currently being pursued (Mark Van Doren, personal communication) and will hopefully 
generate a more comprehensive list of DSX targets to use in such comparisons. Genome-
wide binding site surveys will likely be performed for other terminal sexual regulators in 
the coming years, allowing for comparisons between regulators of sexual differentiation 
across diverse species that will greatly enhance our understanding of this important 
biological process and the degree to which its regulation is conserved. Recently evolved, 
clade-specific sexual differentiations are likely to be regulated by genes that have 
recently been recruited into a role in sexual differentiation and may not play similar roles 
in other clades. However, many sexual differentiation processes, such as sex-specific 
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neural development and sex-specific gonadogenesis, are likely evolutionarily ancient and 
may be controlled by conserved regulators of sexual differentiation that could be revealed 
in such comparisons. 
What is the purpose of such extensive feedback in the C. elegans sex-determination 
pathway? 
ChIP-seq identified TRA-1 binding sites near several genes known to function upstream 
of tra-1 in the sex-determination pathway. In fact, evidence of TRA-1 binding was 
observed near masculinizing genes at every level of the core pathway, and these sites 
included some of the most convincing TRA-1 binding sites identified by ChIP-seq; they 
were among the most enriched sites in every ChIP performed (including in C. briggsae), 
they harbor excellent matches to the TRA-1 consensus binding sequence, and reporter 
analysis suggests that the sites adjacent to xol-1 (Hargitai et al., 2009) and fem-3 drive 
direct male-specific expression in a TRA-1 dependent manner. So these sites appear to be 
real and functional, which raises the question of why so many of them are present. 
Feedback onto fem-3, which directly represses TRA-1 by targeting it for proteasomal 
degradation (Starostina et al., 2007), is likely a cell-autonomous form of feedback 
regulation. This may function to ensure that a cell expressing TRA-1 is incapable of 
expressing high levels of FEM-3 and cannot enter the male mode of sexual development 
even if upstream elements of the pathway or the cell’s ability to interpret them are 
compromised.  
As described in Chapter 1, HER-1 is a secreted factor that functions cell non-
autonomously to promote male development, so TRA-1 binding sites near her-1 and the 
upstream gene xol-1 may represent cell non-autonomous forms of feedback regulation, 
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possibly functioning to coordinate the sex-determination decision between cells. xol-1 
controls both sex determination and dosage compensation, ensuring these processes are 
functioning in the same mode. Sex-inappropriate dosage compensation, either its ectopic 
activity in XO males or inactivity in XX hermaphrodites, is lethal. If the purpose of these 
feedback sites is to ensure faithful execution of the sex-determination pathway, feedback 
upstream of the DCC at the level of xol-1 would ensure that this reinforcement of the 
female mode of sex determination also reinforces the female mode of dosage 
compensation activity. 
Extensive feedback regulation may also be a relic of the evolutionary history of the 
pathway. If the pathway evolved in a bottom-up manner as has been hypothesized 
(Wilkins, 1995), TRA-1 feedback on every male-promoting gene in the pathway may 
simply represent a selective advantage for feedback from TRA-1 onto the most upstream 
male-promoting gene in the pathway throughout this evolutionary history.  
How does TRA-1 regulate transcription? 
All TRA-1 target genes identified prior to this work are male-promoting genes that are 
transcriptionally repressed by TRA-1. Several of the new TRA-1 targets identified here 
show male-specific expression and/or male-specific developmental defects when knocked 
down, but none exhibited hermaphrodite-specific expression or hermaphrodite-specific 
reduction-of-function phenotypes. So TRA-1 appears to act primarily as a transcriptional 
repressor, but the molecular nature of this repression remains unknown.  
Does TRA-1 repress transcription simply by physically binding to its targets and 
preventing the binding of positive regulators? Or does TRA-1 recruit other proteins to its 
binding sites, such as chromatin regulators that establish a repressive chromatin state? 
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Can cis-acting elements other than the TRA-1 consensus binding sequence influence 
TRA-1 binding? 
The list of TRA-1 binding sites identified by ChIP-seq can be used to begin to address 
these questions of TRA-1 function. In Chapter 2, the MEME program was used to 
determine the in vivo TRA-1 consensus binding sequence, which was shown to be a close 
match to the in vitro motif (Zarkower & Hodgkin, 1993). MEME also identified a 
relatively unstructured GAGA motif as enriched at TRA-1 binding sites. This motif is 
roughly twice as likely to be found at TRA-1 consensus binding sequences that are bound 
by TRA-1 than at consensus binding sequences that are not bound by TRA-1 (Figure 
3.1), suggesting that the presence of this GAGA motif may facilitate TRA-1 binding, 
either directly or through the recruitment of a TRA-1 co-regulator. 
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Figure 3.1. Motif searching identifies a GAGA motif enriched at TRA-1 binding 
sites. The 2713 closest matches to the TRA-1 consensus binding sequence in the C. 
elegans genome were grouped into two categories, TRA-1 bound and TRA-1 unbound, 
based on whether or not they showed significant TRA-1 occupancy in L3 stage TRA-1 
ChIP. 48/143 (34%) of TRA-1 bound sites contain a GAGA motif, while 417/2569 (16%) 







The modENCODE consortium has profiled the occupancy of several chromatin marks 
using ChIP-seq (Gerstein et al., 2010). When our TRA-1 binding sites are compared to 
these marks, few correlations are evident, suggesting that recruitment of chromatin 
modifiers that regulate these particular marks is not a major mode of TRA-1 function 
(Figure 3.2). There is a weak association between TRA-1 binding and H3K4 tri-
methylation, which is a chromatin mark associated with active promoter regions. 
However this may simply reflect the tendency of TRA-1 binding sites to lie in promoter 
regions rather than reveal a means of TRA-1 transcriptional repression. Perhaps more 
detailed mapping of the chromatin state of the C. elegans genome will reveal more 
meaningful correlations between TRA-1 binding and chromatin marks that will provide 
clues as to how TRA-1 represses transcription.  
The modENCODE consortium also used ChIP-seq to identify binding sites for many site-
specific transcription factors (Niu et al., 2011). A comparison of the occupancy of these 
transcription factors at TRA-1-bound vs. TRA-1-unbound TRA-1 binding motifs shows a 
modest relationship between TRA-1 occupancy and the occupancy of two of these 
transcription factors (Figure 3.3). TRA-1 bound sites are more likely to be bound by the 
homeobox protein CEH-9, and less likely to be bound by zinc-finger transcription factor 
EOR-1, than TRA-1-unbound sites. This suggests CEH-9 may serve to facilitate and 
EOR-1 binding to restrict TRA-1 binding to its recognition sequence, and that the 
presence or absence of other site specific transcription factors may regulate TRA-1 
binding at other sites.
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Figure 3.2. A comparison of TRA-1 occupancy and chromatin mark occupancy. The 
2713 closest matches to the TRA-1 consensus binding sequence in the C. elegans genome 
were ordered based on their degree of enrichment in L3 stage TRA-1 ChIP. Normalized 
ChIP reads within a 4 kb window centered on each TRA-1 motif are shown for TRA-1 
and 8 chromatin marks. TRA-1 and H3K4me3 show a weak positive correlation. No 







Figure 3.3. A comparison of TRA-1 occupancy and transcription factor occupancy. 
The 2713 closest matches to the TRA-1 consensus binding sequence in the C. elegans 
genome were ordered based on their degree of enrichment in L3 stage TRA-1 ChIP. 
Normalized ChIP reads within a 4 kb window centered on each TRA-1 motif are shown 
for TRA-1 and 3 other site specific transcription factors. Occupancies of CEH-9 and 
TRA-1 show a positive correlation. Occupancies of EOR-1 and TRA-1 show a negative 






How is TRA-1 regulated? 
Previous work has shown that the tra-1 locus produces two transcripts (Zarkower & 
Hodgkin, 1992), and that the protein encoded by the larger transcript, TRA-1A, is C-
terminally cleaved to generate the functional transcriptional regulator (Schvarzstein & 
Spence, 2006). However, it is unclear at exactly which residue this cleavage occurs, and 
what proteins mediate this cleavage event remain unknown. It is also unclear how TRA-1 
protein expression may differ in different cells and at different times. DSX, the terminal 
regulator of sex in Drosophila, has recently been shown to exhibit dynamic expression 
through development, in many cases coming on in particular cells as they execute sex-
specific differentiation events (Robinett, Vaughan, Knapp, & Baker, 2010). Thus spatial 
and temporal control of DSX expression appears to be an important component of 
Drosophila sexual development, and it is unclear whether a similar principle applies in C. 
elegans.  
New approaches to understanding TRA-1 function 
Cell type specific ChIP-seq 
One limitation of the approach described in Chapter 2 is that all ChIPs were performed in 
large batches of whole animals and likely failed to detect sites that are bound by TRA-1 
in only a few cells. One obvious potential solution to this problem is to simply perform 
TRA-1 ChIP-seq specifically in particular cells of interest. Fluorescence assisted cell 
sorting (FACS) can be used to generate very pure populations of cells expressing a 
fluorescent marker, and promoters capable of driving cell-type specific expression of 
such markers are known for many cell types in C. elegans. By coupling FACS and ChIP-
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seq, cell-type specific TRA-1 binding sites could be detected. Of course this is a very 
technically challenging approach, but may be feasible for certain cell types.  
A postdoctoral fellow in the lab, Mary Kroetz, has used FACS to generate large numbers 
(105-106) of highly pure gonadal precursor cells (GPCs) from C. elegans larvae, at a 
timepoint in which these cells represent less than 1% of total cells in the animal (Mary 
Kroetz, personal communication). The fewest cells used in a successful TRA-1 ChIP 
experiment thus far is ~8 x107, but other groups have performed successful site-specific 
transcription factor ChIP-seq experiments in a few as 104 cells (Zwart et al., 2013), 
suggesting that ChIP-seq of TRA-1 from 105-106 GPCs may be feasible. We are currently 
pursuing TRA-1 ChIP-seq using these sorted GPCs in an attempt to identify gonadal 
precursor-specific TRA-1 binding sites. As mentioned in Chapter 2, tra-1 plays a unique 
role in the gonad, promoting gonadal proliferation in both sexes, but nothing is known 
about which TRA-1 target genes are responsible for this activity, making the GPCs a 
particularly interesting tissue in which to perform cell-type specific TRA-1 ChIP-seq. 
Tagging TRA-1 at the endogenous locus 
One of the difficulties in addressing many of the questions described in the first portion 
of this chapter is that the only means to follow the TRA-1 protein currently available is 
the TRA-1 antibody presented in Chapter 2, which does not perform well in many 
applications. A rescuing tagged version of the protein would provide another way to 
examine TRA-1 protein function, but tra-1 is notoriously difficult to rescue with 
transgenes. The tra-1 locus is extremely large for C. elegans, with over 40 kb of sequence 
between the nearest genes on either side. In the compact C. elegans genome, such large 
intergenic regions are quite rare, and often contain important regulatory elements for the 
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adjacent genes. The identification of TRA-1 binding sites in an intron of tra-1 as well as 
several kb upstream of the coding region suggests that this may indeed be the case for 
tra-1. The tra-1 locus is also not covered in current fosmid libraries, possibly owing to 
instability in E. coli (J. Hodgkin, 1993), which makes the generation of a full genomic 
clone of the locus challenging. However, recent advances in C. elegans transgene 
technology provide the exciting prospect of tagging the endogenous tra-1 locus, which 
would avoid the problems of high copy number and missing regulatory elements 
associated with traditional transgenic methods, and potentially generate a strain bearing a 
tagged version of TRA-1 that is capable of rescuing a tra-1 mutant. 
CRISPR-Cas9-mediated genome editing technology is based on the bacterial Cas9 
endonuclease, which generates DNA double-strand breaks (DSBs) at specific target sites 
based on complementary between DNA sequences at those sites and a guide RNA 
associated with the Cas9 enzyme. Guide RNAs can be engineered to target virtually any 
DNA sequence, allowing for the generation of site-specific DSBs that can then be 
repaired via homologous recombination from an exogenously supplied repair template. 
Several groups have demonstrated the utility of this system for engineering the C. elegans 
genome (Frokjaer-Jensen, 2013). I am currently attempting to use this system to generate 
a strain expressing an N-terminally tagged BIOtag::GFP::3XFLAG::TRA-1 protein under 
the control of all the regulatory elements of the endogenous tra-1 locus, which would 
potentially be capable of rescuing a tra-1 null mutation.  
Such a strain would be of great utility in answering several of the questions posed above. 
GFP would allow for the visualization of TRA-1 protein dynamics in living animals, 
shedding light on questions of TRA-1 regulation as well as TRA-1 function. The BIOtag, 
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GFP, and 3XFLAG tags can all be used for protein purifications, either individually or in 
tandem. BIOtag is a sequence of amino acids that includes the substrate and recognition 
site required for biotinylation by the BirA protein. C. elegans does not normally express 
BirA, but stable transgenic strains have been constructed in which regulatory elements 
that direct ubiquitous expression drive BirA expression throughout the animal with no 
phenotypic effects (Ooi, Henikoff, & Henikoff, 2010). Biotinylated proteins can be 
extremely efficiently purified using streptavidin; the biotin-streptavidin interaction is 
among the strongest known non-covalent biomolecular interactions, with a Kd of roughly 
10−14 mol/L (Green, 1975). This is roughly 106 fold higher than the 10−7-10−9 mol/L Kd 
values typical of protein-antibody interactions, making it an excellent means by which to 
perform purifications. High-affinity TRA-1 pulldowns based on the biotin-streptavidin 
interaction could address several of the questions posed above. TRA-1 cleavage sites 
could be accurately mapped, and proteins that physically interact with TRA-1 could be 
identified in Co-IPs. This could potentially identify regulators of TRA-1 activity as well 
as transcriptional co-regulators that may shed light on how TRA-1 functions as a 
transcriptional repressor.  
This strain could also provide a simpler alternative to the technically challenging cell-
specific ChIP-seq experiments described earlier. Driving the birA gene using a cell-type 
specific promoter would generate biotinylated TRA-1 in only those cells in which the 
promoter is active, and subsequent ChIPs using streptavidin beads to pull down 
biotinylated TRA-1 would enrich for sites bound by TRA-1 specifically in those cells, 
potentially allowing for the identification of cell-type specific TRA-1 binding sites that 




The list of TRA-1 binding sites and putative target genes presented here represents an 
important resource for further investigations into the sexual development of C. elegans. 
Determining what role these genes play in the worm will provide a paradigm for 
understanding how sexual differentiation is regulated on the level of an entire organism. 
In addition, this list can be used in comparisons between TRA-1 targets and the 
regulators of sexual differentiation in other species that will greatly enhance our 
understanding of this important biological process and the degree to which its regulation 
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